palladium has been researched along with Cancer of Prostate in 296 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 46 (15.54) | 18.2507 |
| 2000's | 195 (65.88) | 29.6817 |
| 2010's | 49 (16.55) | 24.3611 |
| 2020's | 6 (2.03) | 2.80 |
| Authors | Studies |
|---|---|
| Čanović, P; Jevtić, V; Jovičić Milić, S; Kačániová, M; Kočović, A; Nikolić, I; Petrović, Đ; Radojević, I; Raković, I; Simić, D; Stojković, D; Vukić, M; Vuković, N; Zarić, M; Živković-Zarić, R | 1 |
| Cheng, L; Qin, H; Tao, L; Wang, J; Wang, Y; Zhu, G | 1 |
| Blanchard, P; Bruno, T; Ciezki, J; Crook, JM; Frank, SJ; Keyes, M; Merrick, G; Millar, J; Mok, H; Sanders, J; Singh, T; Song, D; Stock, R; Sullivan, FJ; Swanson, DM; Tang, C; Thames, H | 1 |
| Agarwal, S; Bae, HJ; DeWeese, TL; Greco, S; Habtu, T; Huang, P; Lakshminarayanan, P; McNutt, T; Mian, OY; Narang, A; Peng, LC; Robertson, S; Song, DY; Tran, P | 1 |
| Akar, RO; Ari, F; Aydinlik, S; Aztopal, N; Celikler, S; Cevatemre, B; Erkisa, M; Ulukaya, E; Yilmaz, VT | 1 |
| Cohen, G; Damato, AL; Debonis, D; Gewanter, R; Kollmeier, MA; McBride, S; Mychalczak, B; Varghese, M; Zelefsky, MJ; Zhang, Z | 1 |
| Bae, HJ; Burdette, EC; DeWeese, TL; Le, Y; Lee, J; Mian, OY; Prince, JL; Song, DY | 1 |
| Beaulieu, L; Côté, MF; Fortin, MA; Lagueux, J; Laprise-Pelletier, M; Ma, Y | 1 |
| Choi, HG; Jeong, JH; Jin, SG; Kim, JO; Ku, SK; Lee, YM; Ou, W; Poudel, K; Soe, ZC; Thapa, RK; Yong, CS | 1 |
| Riegel, AC; Taylor, PK | 1 |
| Cevatemre, B; Frame, FM; Maitland, NJ; Mann, VM; Pellacani, D; Simms, MS; Stower, MJ; Ulukaya, E; Walker, H; Yilmaz, VT | 1 |
| Amat di San Filippo, C; Dehghan, E; Fallavollita, P; Fichtinger, G; Morris, WJ; Salcudean, SE | 1 |
| Gao, Z; Hou, L; Tang, D; Xu, M | 1 |
| Chen, J; Lan, J; Lin, J; Wan, Q; Xu, W; Zhang, X | 1 |
| Cohen, GN; Folkert, MR; Hathout, L; Kollmeier, MA; Yamada, Y; Zelefsky, MJ | 1 |
| Casares-Magaz, O; Hernandez-Armas, J; Nuñez-Cumplido, E; Perez-Calatayud, J | 1 |
| Christensen, P; Hao, Y; Hassan, G; Jiang, R; Moeendarbari, S; Mulgaonkar, A; Öz, OK; Ramezani, S; Sun, X; Tekade, R | 1 |
| Gorbacheva, LB; Grekhova, AK | 1 |
| Butler, WM; Merrick, GS | 1 |
| Côté, MF; Fortin, MA; LaGrange, T; Lagueux, J; Laprise-Pelletier, M | 1 |
| Habibi, S; Liu, Y; Nie, Z; Tao, J; Xia, X; Yang, K; Ye, H; Zhang, Q | 1 |
| Oton, CA; Oton, F | 1 |
| Beaulieu, L; Leclerc, G; Lessard, E; Pouliot, J; Villeneuve, M | 1 |
| Allen, Z; Blasko, J; Butler, W; Chaudry, UU; Grimm, P; Merrick, GS; Sitter, M; Sylvester, J | 1 |
| Rogers, DW; Taylor, RE | 2 |
| Allen, ZA; Blasko, J; Butler, WM; Chaudhry, UU; Grimm, P; Merrick, GS; Orio, PF; Sylvester, J | 1 |
| Dash, A; Kumar, Y; Muthe, KP; Saxena, SK; Sharma, SD; Venkatesh, M | 1 |
| Bernardini, S; Condello, R; Conforti, F; Crispini, A; De Martino, A; Federici, G; Ghedini, M; Pucci, D; Rotilio, G; Stellitano, C; Valentini, A | 1 |
| Lucas, S; Nuttens, VE | 1 |
| Feleppa, EJ; Mamou, J; Ramachandran, S | 1 |
| Burri, RJ; Cesaretti, JA; Ho, AY; Stock, RG; Stone, NN | 1 |
| Butler, WM; Merrick, GS; Stewart, RR | 1 |
| Luerman, CM; Meigooni, AS; Sowards, KT | 1 |
| Adams, MT; Basillote, J; Lamonica, J; Lee, HK; Miranda, L; Motta, J; Shi, Q | 1 |
| Ma, L; Ren, YY; Tian, JH; Yang, KH; Zhang, LL | 1 |
| Braccioforte, MH; Chen, MH; D'Amico, AV; Dosoretz, D; Katin, M; Moran, BJ; Nanda, A; Ross, R; Salenius, S | 1 |
| Inciūra, A; Jarusevicus, L; Juozaityte, E; Vaiciūnas, K | 1 |
| Alkaissi, AK; Anscher, MS; Broadwater, G; Chino, JP; Clough, RW; Das, S; Miles, EF; Nelson, JW; Oleson, JR | 1 |
| Demanes, J; Ghilezan, M; Gustafson, GS; Martinez, AA; Schour, L; Vargas, C | 1 |
| Wang, J; Yang, R; Zhang, H | 1 |
| Burri, RJ; Cesaretti, JA; Forsythe, K; Ho, AY; Stock, RG; Stone, NN | 1 |
| Bamberg, M; Kaulich, TW | 1 |
| Burri, RJ; Stock, RG; Stone, NN; Unger, P | 1 |
| Bice, WS; Butler, WM; Chen, Z; Meigooni, AS; Narayana, V; Nath, R; Rivard, MJ; Yu, Y | 1 |
| Ashenafi, MS; Clarke, HS; Marshall, DT; Onicescu, G; Zauls, AJ | 1 |
| Beaulieu, L; Gurp, EB; Keller, B; Landry, G; Lutgens, L; Murrer, L; Pignol, JP; Reniers, B; Verhaegen, F | 1 |
| Sadeghi, M; Saidi, P; Shirazi, A; Tenreiro, C | 1 |
| Coen, JJ; Efstathiou, JA; Grocela, JA; Rossi, CJ; Shipley, WU; Yan, Y; Zietman, AL | 1 |
| Allen, ZA; Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Taira, AV; Wallner, KE | 1 |
| Crook, J | 1 |
| Anscher, MS; Barani, IJ; Lin, PS; Todor, DA | 1 |
| Ennis, RD; Kagen, A; Maletz, KL; Ostenson, J; Pevsner, A; Wernick, I | 1 |
| Adamovich, E; Butler, WM; Galbreath, RW; Lief, J; Merrick, GS; Taira, AV; Wallner, KE | 1 |
| Aguilera, RJ; Contel, M; González-Pantoja, JF; Jarzecki, AA; Robles-Escajeda, E; Royo, E; Stern, M; Varela-Ramírez, A | 1 |
| Ko, EC; Stock, RG; Stone, NN | 1 |
| Blacksburg, S; Forsythe, K; Stock, RG; Stone, N | 1 |
| Adamovich, E; Butler, WM; Galbreath, R; Lief, JH; Merrick, GS; Shetti, MB; Torlone, A; Wallner, KE | 1 |
| Burri, R; Forsythe, K; Stock, RG; Stone, N | 1 |
| Adamovich, E; Butler, WM; Galbreath, RW; Merrick, GS; Orio, P; Taira, AV; Wallner, KE | 1 |
| Chamberlain, D; Cunningham, J; Ding, W; Lee, J; Tay, J; Yang, L | 1 |
| Adamovich, E; Butler, WM; Galbreath, RW; Merrick, GS; Taira, AV; Wallner, KE | 1 |
| Brennan, JS; Christos, PJ; Goltser, Y; Nori, D; Parashar, B; Sabbas, AM; Shamis, M; Trichter, S; Wernicke, AG; Yan, W | 1 |
| Berkowitz, J; Blacksburg, SR; Stock, RG; Stone, NN | 1 |
| Crehange, G; Dea, R; Gottschalk, AR; Hsu, CC; Hsu, H; Hsu, IC; Kurhanewicz, J; Pickett, B; Roach, M; Shinohara, K; Weinberg, V | 1 |
| Buckstein, M; Snyder, KM; Stock, RG; Stone, NN | 1 |
| Buckstein, M; Campbell, C; Cesaretti, J; De Ruysscher, D; Hixson, R; Kerns, SL; Lammering, G; Ostrer, H; Rath, L; Rosenstein, BS; Shao, Y; Stock, R; Stone, N; Terk, M | 1 |
| Chevallier, D; Cosset, JM; Gerbaulet, A; Hannoun-Levi, JM | 1 |
| Dondas, HA; Elboray, EE; Grigg, R; Groome, NM; Inman, MW; Kilner, C; Phillips, RM | 1 |
| Ahmad, S; Algan, O; Ali, I; Sindhwani, P; Thompson, S | 1 |
| Balasubramaniam, M; Chellapandian, TP; Govindarajan, KN; Jayakumar, S; Joshi, P; Nagarajan, M; Nagarajan, V; Sundaram, T; Supe, SS | 1 |
| Boehmer, D; Budach, V; Deger, S; Loening, SA; Roigas, J; Türk, I | 1 |
| Bresnahan, JF; Davis, BJ; Karon, BL; King, BF; Stafford, SL; Wilson, TM | 1 |
| Balakrishnan, SA; Majali, MA; Mathew, C | 1 |
| Garden, R; Gejerman, G; Lanteri, V; Mullokandov, E; Rosen, J; Saini, AJ; Sawczuk, I; Scheuch, J; Vitenson, J | 1 |
| Boyd, JC; Chapman, TN; Makhlouf, AA; Theodorescu, D | 1 |
| Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, KE | 2 |
| Bissonette, EA; Chen, C; Theodorescu, D; Valicenti, RK | 1 |
| Cash, J; Dattoli, M; Sorace, R; True, L; Wallner, K | 3 |
| Barker, J; Merrick, G; Wallner, K | 1 |
| Abascal García, JM; Abascal García, R; Hevia Suarez, M; Juan Rijo, G; Prada Gómez, PJ | 1 |
| Butler, W; Cavanagh, W; Ghaly, M; Merrick, G; Sutlief, S; True, L; Wallner, K | 1 |
| Bohm, TD; DeLuca, PM; DeWerd, LA | 1 |
| Cesaretti, JA; Stock, RG; Stone, NN | 2 |
| Ahmed, SN; Eichling, J; Michalski, J; Mutic, S | 1 |
| Badiozamani, K; Butler, W; Han, BH; Merrick, G; Wallner, K | 1 |
| Bondy, H; Gil-Montero, G; Hendricks, F; Katz, S; Khawand, N; Koutrouvelis, P; Lailas, N; Sehn, J | 1 |
| Beddar, S; Colussi, V; Dinchman, KH; Ellis, RJ; Fu, P; Kim, E; Kinsella, TJ; Resnick, M; Sodee, B; Spirnak, JP; Vertocnik, A; Young, B; Zhou, H | 1 |
| DiBiase, SJ; Li, XA; Stewart, RD; Wang, JZ | 1 |
| Burden, LR; Butler, WM; Dougherty, JE; Merrick, GS; Wallner, KE | 1 |
| Kollmeier, MA; Stock, RG; Stone, N | 1 |
| Stevens, RN; Zheng, JJ | 1 |
| Blasko, JC; Grimm, PD; Malmgren, JA; Meier, R; Sylvester, JE | 1 |
| Kal, HB; Van Gellekom, MP | 1 |
| Lee, WR; Moughan, J; Owen, JB; Zelefsky, MJ | 1 |
| Tucker, RD | 1 |
| Butler, W; Cavanagh, W; Merrick, G; Sutlief, S; True, L; Wallner, K | 1 |
| Chen, PY; Goldman, K; Grills, IS; Gustafson, GS; Hollander, M; Huang, R; Martinez, AA | 1 |
| Hoffelt, SC; Merrick, G; Wallner, K | 1 |
| Adamovich, E; Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, KE | 1 |
| Blute, ML; Frank, I | 1 |
| Broderick, GA; Buskirk, SJ; Igel, TC; Lisson, SW; Wehle, MJ; Young, PR | 1 |
| Colussi, V; Dinchman, KH; Ellis, RJ; Fu, P; Kim, E; Resnick, MI; Sodee, B; Spirnak, JP; Vertocnik, A; Young, B; Zhou, H | 1 |
| Butler, W; Cavanagh, W; Corriveau, J; Merrick, G; Sutlief, S; True, L; Wallner, K | 1 |
| Hong, S; Howard, V; Lo, YC; Stock, RG; Stone, NN | 1 |
| Fearn, P; Huang, D; Kattan, MW; Potters, L | 1 |
| Stock, RG; Stone, NN | 2 |
| Calamia, E; Cattani, F; Giglioli, F; Lappi, S; Longobardi, B; Mangili, P; Martinelli, R; Stea, L; Ziglio, F | 1 |
| Lee, WR | 1 |
| Fukagai, T; Lederer, JL; Morita, M; Shimada, M; Yoshida, H | 2 |
| Dauer, LT; Horan, C; St Germain, J; Yamada, Y; Zelefsky, MJ | 1 |
| Feng, AC; Fuller, DB; Koziol, JA | 1 |
| Allen, Z; Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Murray, B; Wallner, KE | 1 |
| Butler, W; Cavanagh, W; Ford, E; Merrick, G; Mueller, A; Sutlief, S; Wallner, K | 1 |
| Nori, D; Reddy, NM; Shemtov, MM; Vaughan, ED | 1 |
| Cahlon, O; Cesaretti, JA; Kollmeier, MA; Stock, RG; Stone, NN | 1 |
| Adamovich, E; Allen, Z; Butler, WM; Hinerman-Mulroy, A; Merrick, GS; Wallner, KE | 1 |
| Ellis, RJ; Kinsella, TJ; Kunos, CA; Resnick, MI | 1 |
| Brinkmann, DH; Davis, BJ; Herman, MG; Kline, RW; Kruse, JJ; LaJoie, WN; Pisansky, TM; Schwartz, DJ | 1 |
| Collins, B; Dritschilo, A; Gagnon, G; Lynch, J; McRae, D; Niroomand-Rad, A; Regan, J; Singh, AM; Zhang, Y | 1 |
| Chappell, R; Fowler, J; Ritter, M | 2 |
| Adamovich, E; Butler, WM; Galbreath, RW; Merrick, GS; Wallner, KE | 1 |
| Butler, W; Cavanagh, W; Ford, E; Merrick, G; Sherertz, T; Sutlief, S; True, L; Wallner, K | 1 |
| Clark, JR; Koona, RA; Meigooni, AS; Rachabatthula, V; Zhang, H | 1 |
| Bellomi, M; Cattani, F; De Cobelli, O; Marsiglia, H; Orecchia, R; Origgi, D; Polo, A; Tosi, G; Vavassori, A; Villa, G | 1 |
| Chawla, R; Joneja, OP; Popowski, Y; Zilio, VO | 1 |
| Adamovich, E; Allen, Z; Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, KE | 1 |
| Schild, SE; Schwartz, DJ; Vora, SA; Wong, WW | 1 |
| Rubenstein, J | 1 |
| Cosset, JM; Mettler, F; Pinillos-Ashton, L | 1 |
| Behar, RJ; Cantor, A; Chovnick, SD; Huff, W; Otheguy, J; Perez, R; Rabinowitz, R; Sharkey, J; Solc, Z | 1 |
| Büchler, F; Hawliczek, R; Madersbacher, S; Maier, U; Oismüller, R; Ponholzer, A; Rauchenwald, M; Somay, C | 1 |
| Butler, W; Merrick, G; Sutlief, S; True, L; Wallner, K | 1 |
| Bissonette, E; Miller, N; Smolkin, ME; Theodorescu, D | 1 |
| Bissonette, EA; Copp, H; Theodorescu, D | 1 |
| Hertel, NE; Wang, Z | 1 |
| Butler, W; Cavanagh, W; Merrick, G; Sherertz, T; Sutlief, S; True, L; Wallner, K | 1 |
| Armstrong, J; Butler, W; Cavanagh, W; Lin, D; Merrick, G; Mueller, A; Seeberger, J; Tran, A; Wallner, K | 1 |
| Cho, PS; Ford, EC; Narayanan, S; Reed, DR; Sutlief, SG; Wallner, KE | 1 |
| Momma, T; Ohashi, T; Saito, S; Toya, K; Yorozu, A | 1 |
| Awan, SB; Koona, RA; Meigooni, AS; Rachabatthula, V | 1 |
| Chibani, O; Todor, D; Williamson, JF | 1 |
| Adamovich, E; Allen, ZA; Butler, WM; Galbreath, RW; Merrick, GS; Niehaus, A; Wallner, KE | 1 |
| Cesaretti, JA; Rosenstein, BS; Stock, RG; Stone, NN | 1 |
| Adamovich, E; Allen, Z; Butler, WM; Galbreath, RW; Gutman, S; Merrick, GS; Wallner, KE | 1 |
| Allen, ZA; Aronowitz, J; Blasko, JC; Butler, WM; Grimm, P; Lief, JH; McLaughlin, PW; Merrick, GS; Michalski, J; Moran, BJ; Usher, J; Wallner, KE | 1 |
| Chibani, O; Williamson, JF | 1 |
| Cambria, R; Cattani, F; Orecchia, R; Polo, A; Rondi, E; Tosi, G; Vavassori, A | 1 |
| Feinstein, JM; Jani, AB; Krengel, S; Pasciak, R; Weichselbaum, RR | 1 |
| Calugaru, E; Jassal, A; Potters, L; Presser, J | 1 |
| Adamovich, E; Allen, ZA; Butler, WM; Galbreath, RW; Merrick, GS; True, L; Wallner, KE | 1 |
| Blasko, JC; Galbreath, RW; Grimm, PD; Merrick, G; Millar, J; Orio, PF; Skoglund, S; Sylvester, JE | 1 |
| Beyer, DC; Blasko, JC; Ciezki, JP; Elshaikh, M; Horwitz, EM; Kuban, DA; Levy, LB; Moran, BJ; Pisansky, TM; Potters, L; Zelefsky, MJ; Zietman, AL | 1 |
| Butler, W; Herstein, A; Merrick, G; Mitsuyama, P; Orio, P; Sutlief, S; Thornton, K; Wallner, K | 1 |
| Carey, B; Swift, S | 1 |
| Atencio, DP; Burri, RJ; Cesaretti, JA; Peters, CA; Peters, SA; Rosenstein, BS; Stock, RG; Stone, NN | 1 |
| Allen, Z; Bostancic, C; Butler, WM; Galbreath, R; Gutman, SE; Lief, J; Merrick, GS; Wallner, KE | 1 |
| Adamovich, E; Allen, ZA; Anderson, RL; Butler, WM; Galbreath, RW; Grammer, R; Kurko, B; Merrick, GS; True, L; Wallner, KE | 1 |
| Kerr, C | 1 |
| Ciezki, JP; Davis, BJ; Fearn, PA; Kattan, MW; Potters, L; Roach, M; Stock, RG; Stone, NN; Zelefsky, MJ | 1 |
| Arthurs, S; Cho, PS; Kim, Y; Merrick, G; Narayanan, S; Orio, PF; Tutar, IB; Wallner, KE | 1 |
| Hede, K | 1 |
| Bahnson, RR; Gupta, N; Liu, B; Nag, S; Shi, P; Wang, JZ | 1 |
| Dattoli, M; Fang, LC; Sorace, R; Taira, A; True, L; Wallner, K | 1 |
| Butler, W; Herstein, A; Merrick, G; Orio, P; Sutlief, S; Thornton, K; Wallner, K | 1 |
| Dibiase, SJ; Halabi, S; Hurwitz, MD; Keuttel, MR; McGinnis, LS; Ou, SS; Small, EJ | 1 |
| Klein, G; Ramin, SA; Stock, R; Stone, NN; Unger, P; Wesson, MF | 1 |
| Dawson, JE; Gu, JY; Kim, H; Roy, T; Wu, T | 1 |
| Badalament, R; Burgers, J; Hall, SA; Nag, S; Scaperoth, DD | 1 |
| Forman, JD; Porter, AT | 1 |
| Kline, RW; Mellenberg, DE | 1 |
| DeWyngaert, JK; Lavagnini, P; Stock, RG; Stone, NN; Unger, PD | 1 |
| Acosta, R; Binder, M; Brown, C; Brunelle, R; Cash, J; Dattoli, M; Etheridge, J; Kirwan, N; Koval, J; Sanchez, S; Sorace, R; Stein, D; Wallner, K; Wasserman, S | 1 |
| Hargis, R; Zachow, SE | 1 |
| Schell, MC; Yu, Y | 1 |
| Ragde, H | 1 |
| Blasko, JC; Cavanagh, W; Grimm, PD; Hoak, DC; Prestidge, BR; Ragde, H | 1 |
| Dattoli, M; Lee, H; Wallner, K; Wasserman, S | 1 |
| Martínez-Monge, R; Nag, S; Vivekanandam, S | 1 |
| Ben-Josef, E; Shamsa, F | 1 |
| Cash, JC; Dattoli, MJ | 1 |
| Bice, WS; Friedland, JL; Grimm, PD; Prestidge, BR; Prete, JJ; Stock, RG | 1 |
| Bice, WS; Kiefer, EJ; Prestidge, BR; Prete, JJ | 1 |
| Behar, RJ; Cantor, A; Chovnick, SD; Huff, W; Otheguy, J; Perez, R; Sharkey, J; Solc, Z | 1 |
| Parida, GR; Park, JB; Paulus, JA; Tucker, RD | 1 |
| Corn, BW; Dicker, AP; Waterman, FM; Yue, N | 1 |
| Butler, WM; Dorsey, AT; Merrick, GS; Walbert, HL | 1 |
| Zietman, A | 1 |
| Wuu, CS; Zaider, M | 1 |
| Blasko, JC; Clifford, S; Griffin, TW; Grimm, PD; Luse, R; Ragde, H; Sylvester, J; Tapen, EM | 1 |
| Corn, BW; Dicker, AP; Nath, R; Waterman, FM; Yue, N | 1 |
| Mellenberg, DE; Pennington, EC | 1 |
| Blatt, HJ; Butler, WM; Dorsey, AT; Lief, JH; Merrick, GS; Walbert, HL | 1 |
| Butler, WM; Dorsey, AT; Lief, JH; Merrick, GS | 4 |
| Dicker, AP; Nath, R; Waterman, FM; Yue, N | 1 |
| Beyer, D; Friedland, J; Grimm, P; Nag, S; Nath, R | 1 |
| Brasacchio, RA; Messing, EM; Okunieff, PG; Rubens, DJ; Schell, MC; Soni, A; Strang, JG; Yu, Y; Zhang, JB | 1 |
| Arger, P; Arjomandy, B; Broderick, GA; Epperson, RD; Kassaee, A; Malkowicz, SB; Whittington, R | 1 |
| Ashley, R; Gelblum, DY; Leibel, S; Potters, L; Waldbaum, R; Wang, XH | 1 |
| Gaildon, M; Lo, YC; Stock, RG; Stone, NN | 1 |
| Ashley, R; Cha, CM; Freeman, K; Leibel, S; Potters, L; Waldbaum, R; Wang, XH | 1 |
| Bergsagel, C; Blasko, J; Hudson, RH; Korssjoen, T; Smathers, S; Sutlief, S; Wallner, K | 1 |
| Molloy, JA; Williams, MB | 1 |
| Wallace, RE | 1 |
| Dicker, AP; Waterman, FM | 1 |
| Acosta, R; Binder, M; Biswas, M; Cash, J; Dattoli, M; Kirwan, N; Koval, J; Lastarria, E; Sorace, R; Stein, D; Sullivan, B; True, L; Wallner, K | 1 |
| Chen, Z; Dicker, AP; Nath, R; Peschel, R; Waterman, FM; Yue, N | 1 |
| Chen, Z; Nath, R; Peschel, RE; Roberts, K | 1 |
| DiPetrillo, TA; King, CR; Wazer, DE | 1 |
| Benson, ML; Butler, WM; Dorsey, AT; Lief, JH; Merrick, GS | 1 |
| Rosenzweig, DP; Schell, MC; Yu, Y | 1 |
| Badiozamani, KR; Blasko, JC; Cavanagh, W; Grimm, PD; Hoak, D; Sylvester, JE | 1 |
| Blasko, J; Dibiase, S; Ellis, W; Loblaw, DA; Russell, K; Wallner, K | 1 |
| Potters, L; Wang, XH; Yamada, Y | 1 |
| Butler, WM; Coram, RJ; Dorsey, AT; Lief, JH; Merrick, GS | 1 |
| Behar, RJ; Cantor, A; Chovnick, SD; Donohue, M; Huff, W; Otheguy, J; Perez, R; Rabinowitz, R; Sharkey, J; Solc, Z; Steele, J; Webster, C | 2 |
| Bice, WS; Case, GD; Dubois, DF; Freeman, JE; Prestidge, BR; Prete, JJ; Russell, LF | 1 |
| Potters, L | 1 |
| Ennis, RD; Lee, EK; Schiff, PB; Wuu, CS; Zaider, M | 1 |
| Chen, Z; Nath, S; Peschel, R; Trumpore, S; Yue, N | 1 |
| Meigooni, AS; Soldano, M; Sowards, K | 1 |
| Fan, JJ; Li, Z; Palta, JR | 1 |
| Nag, S | 1 |
| Dicker, AP; Leeper, DB; Lin, CC; Waterman, FM | 1 |
| Blasko, JC; Cavanagh, W; Grimm, PD; Sylvester, JE | 1 |
| Chen, Z; Nath, R; Peschel, R; Roberts, KB; Wang, X; Yue, N | 1 |
| Baird, MC; Holt, RW; Selby, TL | 1 |
| Kao, J; Stock, RG; Stone, NN; Unger, P | 1 |
| Beyer, DC; Brachman, DG; Hilbe, J; Thomas, T | 1 |
| King, CR | 1 |
| Caride, VJ; Colomb, PF; Sheehan, JJ | 1 |
| Bostwick, D; Kuban, D; Moriarty, R; Schellhammer, PF | 1 |
| Blatt, H; Butler, WM; Dorsey, AT; Galbreath, RW; Lief, JH; Merrick, GS | 1 |
| Aus, G; Gunnarsson, G; Nodbrant, P | 1 |
| Iannuzzi, C; Kao, J; Stock, RG; Stone, NN; Unger, P | 1 |
| Butler, WM; Donzella, JG; Dorsey, AT; Lief, JH; Merrick, GS | 1 |
| Leibel, SA; Lombardi, D; Raben, A; Singh, A; Zelefsky, MJ | 1 |
| Coursey, BM; Lamperti, PJ; Mitch, MG; Seltzer, SM; Zimmerman, BE | 1 |
| Blasko, JC; Cavanagh, W; Grimm, PD; Sylsvester, JE | 1 |
| Butler, WM; Dorsey, AT; Hagedorn, BM; Merrick, GS | 1 |
| Bice, WS; Prestidge, BR; Sarosdy, MF | 1 |
| Vikram, B | 2 |
| Lee, PC; Moran, BJ | 1 |
| Anderson, RS; King, P | 1 |
| Michalski, JM; Williamson, JF | 1 |
| Albert, PS; Cavanagh, W; Israeli, R; Lederman, GS; Lessing, J; Savino, M; Volpicella, F | 1 |
| Brezovich, IA; Duan, J; Fiveash, J; Pareek, PN | 1 |
| Battista, J; Lindsay, P; Van Dyk, J | 1 |
| Potters, L; Wang, XH | 1 |
| Gillenwater, JY; Glembocki, DJ; Krupski, TL; Older, RA; Synder, B | 1 |
| Benson, ML; Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, K | 1 |
| Calugaru, E; Cao, Y; Fearn, P; Potters, L; Torre, T; Wang, XH | 1 |
| Anscher, MS; Bowen, MG; Buckley, NJ; Chou, RH; Clough, RW; Das, SK; Dodge, RK; Ingram, SS; Joyner, RE; Kang, HL; Kang, SK; Kim, JH; Montana, GS; Sarmina, I; Steffey, BA; Whitehurst, AW; Zhou, SM | 1 |
| Dokiya, T; Momma, T; Murai, M; Saito, S | 1 |
| Smathers, S; Sprouse, J; True, L; Wallner, K | 1 |
| Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS | 2 |
| Walsh, P | 1 |
| Butler, WM; Lief, JH; Merrick, GS; Sutlief, S; Wallner, K | 1 |
| Billingsley, K; Dominitz, JA; Han, B; Smith, S; Sutlief, S; True, L; Wallner, K | 1 |
| Antipas, V; Coles, IP; Dale, RG | 1 |
| Böhmer, D; Budach, V; Deger, S; Loening, SA; Roigas, J; Türk, I | 1 |
| Adamovich, E; Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS | 2 |
| Lee, LN; Stock, RG; Stone, NN | 1 |
| Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Tollenaar, BG | 1 |
| Abel, LJ; Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Stipetich, RL | 1 |
| Able, AM; Artiles, C; Banks, SJ; Blair, DN; Clarke, DH; Hindle, WV; Houk, RR; Klousia, JW; Lissy, JM; Miller, M; Sheridan, MJ; Wiederhorn, AR | 1 |
| Chen, CT; Dicker, AP; Gomella, LG; Strup, SE; Valicenti, RK; Waterman, FM | 1 |
| Chen, Z; Nath, R; Yue, N | 1 |
| Anscher, MS; Buckley, NJ; Chou, RH; Clough, RW; Dodge, RK; Hahn, CA; Ingram, SS; Joyner, RE; Kang, HS; Kang, SK; Kim, JH; Montana, GS; Whitehurst, AW | 1 |
| Barnswell, C; Fearn, P; Kattan, M; Lee, LN; Potters, L; Torre, T | 1 |
| Butler, W; Corriveau, J; Jones, S; Merrick, G; Sutlief, S; True, L; Wallner, K | 1 |
| Battermann, JJ; Kal, HB; Moerland, MA; Van Gellekom, MP | 1 |
| Dogan, N; Flanigan, RC; Glasgow, GP; Keys, K; Mohideen, N | 1 |
| Pedley, ID | 1 |
| DeMarco, JJ; Hugo, G; Solberg, TD | 1 |
| Nath, R; Yue, N | 1 |
| Anderson, RL; Butler, WM; Galbreath, RW; Kurko, BS; Lief, JH; Merrick, GS; Wallner, K | 1 |
| Huidobro, C; Larson, T; Platz, CE; Tucker, RD | 1 |
| Meigooni, AS; Melillo, A; Nath, R | 1 |
| Brosman, SA; Tokita, K | 2 |
15 review(s) available for palladium and Cancer of Prostate
| Article | Year |
|---|---|
[(125)I versus (103)Pd brachytherapy for low risk prostate cancer: a systematic review].
Topics: Brachytherapy; Databases, Bibliographic; Disease-Free Survival; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Randomized Controlled Trials as Topic; Rectal Diseases; Urologic Diseases | 2009 |
[Review on the effectiveness of prostate cancer brachytherapy].
Topics: Aged; Aged, 80 and over; Brachytherapy; Cohort Studies; Erectile Dysfunction; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Palladium; Prognosis; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Ultrasonography; Urinary Retention | 2009 |
The role of brachytherapy in the definitive management of prostate cancer.
Topics: Adenocarcinoma; Biopsy; Brachytherapy; Combined Modality Therapy; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Organs at Risk; Palladium; Patient Selection; Prostatic Neoplasms; Quality Assurance, Health Care; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Randomized Controlled Trials as Topic; Tomography, X-Ray Computed; Urination Disorders | 2011 |
[Evolution of prostate cancer brachytherapy].
Topics: Brachytherapy; Evidence-Based Medicine; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radiation Protection; Radioisotopes; Radiotherapy Dosage; Risk | 2012 |
Use of interstitial temperature self-regulating thermal rods in the treatment of prostate cancer.
Topics: Alloys; Biocompatible Materials; Cobalt; Humans; Hyperthermia, Induced; Male; Palladium; Prostatic Neoplasms; Transurethral Resection of Prostate; Treatment Outcome | 2003 |
Preliminary toxicity and prostate-specific antigen response of a Phase I/II trial of neoadjuvant hormonal therapy, 103Pd brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of locally advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Brachytherapy; Chemotherapy, Adjuvant; Flutamide; Follow-Up Studies; Humans; Leuprolide; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy, Conformal | 2002 |
The impact of technological advances on the evolution of 3D conformal brachytherapy for early prostate cancer.
Topics: Brachytherapy; Dose-Response Relationship, Radiation; Equipment Design; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Palladium; Prostatic Neoplasms; Radiometry; Radiotherapy Planning, Computer-Assisted; Risk; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Mortuary Practice; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Palladium; Prostatic Neoplasms; Radiation Injuries; Radiation Monitoring; Radiation Protection; Radioactive Waste; Radioisotopes; Radiotherapy Dosage | 2005 |
The current role of imaging for prostate brachytherapy.
Topics: Adenocarcinoma; Biomarkers, Tumor; Brachytherapy; Drug Implants; Fluoroscopy; Follow-Up Studies; Forecasting; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neoplasm Recurrence, Local; Organ Size; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiology, Interventional; Radiopharmaceuticals; Radiotherapy Dosage; Tumor Burden; Ultrasonography; Ultrasound, High-Intensity Focused, Transrectal; Urination Disorders | 2007 |
Prostate brachytherapy. An overview.
Topics: Brachytherapy; Gold Radioisotopes; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Ytterbium | 1993 |
Management of patients receiving transperineal palladium-103 prostate implants.
Topics: Brachytherapy; Erectile Dysfunction; Humans; Male; Palladium; Perioperative Care; Prostatic Neoplasms; Radioisotopes | 1997 |
American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer.
Topics: Biopsy; Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Patient Selection; Postoperative Care; Prostatic Neoplasms; Quality Assurance, Health Care; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; United States | 1999 |
[Brachytherapy with palladium-103--a new way to deliver radiation therapy for localized prostatic cancer].
Topics: Brachytherapy; Humans; Male; Models, Biological; Palladium; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals | 2000 |
Is alpha/beta for prostate tumors really low?
Topics: Algorithms; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radiation Tolerance; Radiobiology; Radioisotopes | 2001 |
Transperineal interstitial permanent prostate brachytherapy for carcinoma of the prostate.
Topics: Brachytherapy; Carcinoma; Humans; Iodine Radioisotopes; Male; Palladium; Patient Selection; Perineum; Prostatic Neoplasms; Radiotherapy Dosage | 2002 |
33 trial(s) available for palladium and Cancer of Prostate
| Article | Year |
|---|---|
High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancer.
Topics: Aged; Brachytherapy; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiotherapy, Intensity-Modulated; Survival Analysis; Treatment Outcome | 2010 |
Comparison of high-dose proton radiotherapy and brachytherapy in localized prostate cancer: a case-matched analysis.
Topics: Age Factors; Aged; Brachytherapy; California; Case-Control Studies; Humans; Iodine Radioisotopes; Male; Massachusetts; Middle Aged; Neoplasm Grading; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Proton Therapy; Radioisotopes; Radiotherapy Dosage; Radiotherapy, Conformal; Seminal Vesicles; Treatment Failure | 2012 |
20 Gy versus 44 Gy of supplemental external beam radiotherapy with palladium-103 for patients with greater risk disease: results of a prospective randomized trial.
Topics: Aged; Androgen Antagonists; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Male; Neoplasm Grading; Palladium; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Survival Rate | 2012 |
A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.
Topics: Age Factors; Aged; Brachytherapy; Erectile Dysfunction; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Polymorphism, Single Nucleotide; Prospective Studies; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal | 2013 |
Interstitial hyperthermia using self-regulating thermoseeds combined with conformal radiation therapy.
Topics: Aged; Cobalt; Combined Modality Therapy; Disease Progression; Humans; Hyperthermia, Induced; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy, Conformal; Treatment Outcome | 2002 |
Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy.
Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Biopsy; Brachytherapy; Doxazosin; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Postoperative Complications; Prazosin; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention; Urination Disorders | 2002 |
Gross hematuria after prostate brachytherapy.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Follow-Up Studies; Hematuria; Humans; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Conformal; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome | 2003 |
The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: morbidity outcomes from two prospective randomized multicenter trials.
Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Aged; Brachytherapy; Diarrhea; Dose Fractionation, Radiation; Follow-Up Studies; Hemorrhage; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiotherapy, High-Energy; Rectal Diseases; Urinary Incontinence; Urinary Retention | 2003 |
The effect of interobserver differences in post-implant prostate CT image interpretation on dosimetric parameters.
Topics: Humans; Iodine Radioisotopes; Male; Observer Variation; Palladium; Postoperative Care; Prostatic Neoplasms; Quality Control; Radioisotopes; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2003 |
125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial.
Topics: Aged; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes | 2003 |
Epididymitis after prostate brachytherapy.
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Brachytherapy; Citrobacter freundii; Cohort Studies; Disease Susceptibility; Enterobacteriaceae Infections; Epididymitis; Escherichia coli Infections; Humans; Incidence; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Risk Factors; Surveys and Questionnaires; Time Factors | 2004 |
Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.
Topics: Brachytherapy; Combined Modality Therapy; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Humans; Male; Palladium; Prostatic Neoplasms; Prostheses and Implants; Radioisotopes; Radiotherapy, Conformal; Rectal Diseases; Time Factors; Treatment Outcome; Urinary Retention | 2003 |
Preliminary toxicity and prostate-specific antigen response of a Phase I/II trial of neoadjuvant hormonal therapy, 103Pd brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of locally advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Brachytherapy; Chemotherapy, Adjuvant; Flutamide; Follow-Up Studies; Humans; Leuprolide; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy, Conformal | 2002 |
Assessment of radiation safety instructions to patients based on measured dose rates following prostate brachytherapy.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Patient Education as Topic; Prostatic Neoplasms; Radiation Monitoring; Radioisotopes; Radiometry | 2004 |
Perirectal seeds as a risk factor for prostate brachytherapy-related rectal bleeding.
Topics: Brachytherapy; Gastrointestinal Hemorrhage; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Rectal Diseases; Rectum; Tomography, X-Ray Computed | 2004 |
Combined modality treatment in the management of high-risk prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Brachytherapy; Combined Modality Therapy; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Testosterone | 2004 |
Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancer.
Topics: Aged; Brachytherapy; Hemorrhage; Humans; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Rectal Diseases | 2004 |
High-dose regions versus likelihood of cure after prostate brachytherapy.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Treatment Failure | 2005 |
20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: preliminary biochemical outcomes from a prospective randomized multi-center trial.
Topics: Aged; Brachytherapy; Humans; Male; Middle Aged; Palladium; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage | 2005 |
Rectal fistulas after prostate brachytherapy.
Topics: Aged; Analysis of Variance; Brachytherapy; Gastrointestinal Hemorrhage; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioisotopes; Rectal Diseases; Rectal Fistula | 2005 |
Intraoperative fluoroscopic dose assessment in prostate brachytherapy patients.
Topics: Brachytherapy; Fluoroscopy; Humans; Intraoperative Period; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy Dosage; Tomography, X-Ray Computed | 2005 |
Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation.
Topics: Brachytherapy; Disease-Free Survival; Humans; Male; Multivariate Analysis; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Tomography, X-Ray Computed | 2007 |
Isotope and patient age predict for PSA spikes after permanent prostate brachytherapy.
Topics: Age Factors; Aged; Analysis of Variance; Androgen Antagonists; Brachytherapy; Disease-Free Survival; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes | 2007 |
Dosimetry of an extracapsular anulus following permanent prostate brachytherapy.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radiation Dosage; Radioisotopes | 2007 |
There is a wide range of predictive dosimetric factors for I-125 and pd-103 prostate brachytherapy.
Topics: Adenocarcinoma; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Risk Assessment; Survival Rate; Tomography, X-Ray Computed | 2008 |
Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgens; Biomarkers; Brachytherapy; Dose Fractionation, Radiation; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiotherapy, Conformal; Seminal Vesicles | 2008 |
Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Biopsy; Brachytherapy; Combined Modality Therapy; Erectile Dysfunction; Follow-Up Studies; Humans; Iodine Radioisotopes; Life Tables; Male; Middle Aged; Neoplasm Staging; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiotherapy Dosage; Treatment Outcome; Ultrasonography; Urination Disorders | 1996 |
Influence of prophylactic dexamethasone on edema following prostate brachytherapy.
Topics: Brachytherapy; Dexamethasone; Edema; Glucocorticoids; Humans; Iodine Radioisotopes; Male; Palladium; Perineum; Prostate; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2000 |
A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy.
Topics: Adenocarcinoma; Brachytherapy; Cohort Studies; Disease-Free Survival; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Palladium; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Tomography, X-Ray Computed | 2001 |
Brachytherapy for prostate cancer in Japan.
Topics: Aged; Aged, 80 and over; Brachytherapy; Humans; Iridium Radioisotopes; Japan; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Survival Analysis; Treatment Outcome | 2001 |
Short-term sexual function after prostate brachytherapy.
Topics: Aged; Brachytherapy; Dose-Response Relationship, Radiation; Erectile Dysfunction; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Surveys and Questionnaires; Time Factors | 2001 |
Interstitial hyperthermia using thermoseeds in combination with conformal radiotherapy for localized prostate cancer.
Topics: Adenocarcinoma; Aged; Cobalt; Combined Modality Therapy; Drug Implants; Electromagnetic Phenomena; Follow-Up Studies; Hot Temperature; Humans; Hyperthermia, Induced; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiation Injuries; Radiotherapy, Conformal; Treatment Outcome | 2002 |
Clinical correlates of high intraprostatic brachytherapy dose volumes.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rectum; Urinary Bladder | 2002 |
249 other study(ies) available for palladium and Cancer of Prostate
| Article | Year |
|---|---|
Newly synthesized palladium(II) complexes with aminothiazole derivatives:
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Cell Line, Tumor; Humans; Male; Palladium; Prostatic Neoplasms; Thiazoles; Underage Drinking | 2022 |
Cytotoxic Action of Palladium-Based Compound on Prostate Stem Cells, Primary Prostate Epithelial Cells, Prostate Epithelial Cells, and Prostate Cell Lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Epithelial Cells; Etoposide; Humans; Male; Palladium; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Stem Cells | 2022 |
Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study.
Topics: Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Retrospective Studies | 2023 |
Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer.
Topics: Aged; Brachytherapy; Dose-Response Relationship, Radiation; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Organs at Risk; Palladium; Patient Reported Outcome Measures; Penile Erection; Prognosis; Prospective Studies; Prostate; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Spatio-Temporal Analysis; Time Factors | 2020 |
A promising therapeutic combination for metastatic prostate cancer: Chloroquine as autophagy inhibitor and palladium(II) barbiturate complex.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Barbiturates; Chloroquine; Coordination Complexes; Humans; Male; Neoplasm Metastasis; Palladium; PC-3 Cells; Prostatic Neoplasms | 2020 |
Low-Dose-Rate Brachytherapy Combined With Ultrahypofractionated Radiation Therapy for Clinically Localized, Intermediate-Risk Prostate Cancer: Results From a Prospective Trial.
Topics: Aged; Brachytherapy; Humans; Male; Middle Aged; Organs at Risk; Palladium; Penile Erection; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Radiation Dose Hypofractionation; Radiation Injuries; Radioisotopes; Rectum; Seminal Vesicles; Urination Disorders | 2020 |
Intraoperative Registered Ultrasound and Fluoroscopy (iRUF) for dose calculation during prostate brachytherapy: Improved accuracy compared to standard ultrasound-based dosimetry.
Topics: Brachytherapy; Fluoroscopy; Humans; Intraoperative Care; Male; Palladium; Pilot Projects; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2017 |
Intratumoral Injection of Low-Energy Photon-Emitting Gold Nanoparticles: A Microdosimetric Monte Carlo-Based Model.
Topics: Animals; Brachytherapy; Gold; Humans; Injections, Intralesional; Male; Metal Nanoparticles; Mice; Monte Carlo Method; Palladium; PC-3 Cells; Photons; Prostatic Neoplasms; Radioisotopes; Radiometry | 2018 |
Palladium nanoparticle-decorated 2-D graphene oxide for effective photodynamic and photothermal therapy of prostate solid tumors.
Topics: Antineoplastic Agents; Cell Cycle; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Graphite; Humans; Male; Metal Nanoparticles; Palladium; Particle Size; PC-3 Cells; Photochemotherapy; Prostatic Neoplasms; Surface Properties | 2018 |
Reducing seed waste and increasing value of dynamic intraoperative implantation of Pd-103 seeds in prostate brachytherapy.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Isotopes; Male; Palladium; Prostatic Neoplasms; Radiotherapy Dosage; Retrospective Studies | 2018 |
Differential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cells.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Cycle; Cell Line; Cell Proliferation; DNA Damage; Epithelial Cells; Humans; Inhibitory Concentration 50; Male; Neoplastic Stem Cells; Palladium; Prostate; Prostatic Neoplasms | 2013 |
Intraoperative segmentation of iodine and palladium radioactive sources in C-arm images.
Topics: Algorithms; Brachytherapy; Endosonography; Humans; Imaging, Three-Dimensional; Iodine Radioisotopes; Male; Monitoring, Intraoperative; Palladium; Prostatic Neoplasms; Radiation Dosage; Radioisotopes; Surgery, Computer-Assisted | 2014 |
Enhanced colorimetric immunoassay accompanying with enzyme cascade amplification strategy for ultrasensitive detection of low-abundance protein.
Topics: Alkaline Phosphatase; Antibodies, Monoclonal; Benzidines; Biomarkers; Catalysis; Colorimetry; Enzyme Assays; Humans; Hydrogen Peroxide; Immunoassay; Male; Metal Nanoparticles; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Sensitivity and Specificity | 2014 |
Colorimetric determination of sarcosine in urine samples of prostatic carcinoma by mimic enzyme palladium nanoparticles.
Topics: Biomimetic Materials; Calibration; Colorimetry; Horseradish Peroxidase; Humans; Male; Metal Nanoparticles; Palladium; Prostatic Neoplasms; Sarcosine; Temperature; Urinalysis | 2014 |
Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning.
Topics: Aged; Analysis of Variance; Area Under Curve; Brachytherapy; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiotherapy Dosage; Retrospective Studies; ROC Curve; Urinary Bladder; Urination Disorders | 2014 |
Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants.
Topics: Algorithms; Brachytherapy; Humans; Iodine Radioisotopes; Male; Models, Biological; Organs at Risk; Palladium; Prostate; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Urethra | 2015 |
Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors.
Topics: Animals; Brachytherapy; Cell Line, Tumor; Gold; Humans; Male; Metal Nanoparticles; Mice; Mice, SCID; Nanostructures; Palladium; Particle Size; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Theranostic Nanomedicine; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous | 2016 |
Generation of Reactive Oxygen Species in Peripheral Blood Lymphocytes of Patients with Prostate Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cisplatin; Humans; Lymphocytes; Male; Middle Aged; Oxidation-Reduction; Palladium; Prostatic Neoplasms; Reactive Oxygen Species | 2016 |
Focal prostate brachytherapy with (103)Pd seeds.
Topics: Biopsy; Brachytherapy; Humans; Imaging, Three-Dimensional; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Treatment Outcome; Ultrasonography | 2016 |
Low-Dose Prostate Cancer Brachytherapy with Radioactive Palladium-Gold Nanoparticles.
Topics: Animals; Brachytherapy; Cell Line, Tumor; Gold; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Palladium; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2017 |
An Enzyme-Free Signal Amplification Technique for Ultrasensitive Colorimetric Assay of Disease Biomarkers.
Topics: Biomarkers; Colorimetry; Enzyme-Linked Immunosorbent Assay; Gold; Humans; Iridium; Male; Metal Nanoparticles; Palladium; Particle Size; Prostate-Specific Antigen; Prostatic Neoplasms | 2017 |
Brachytherapy doses for prostate cancer customized to risk factors: is it more important "how much" or "where"? In regard to Stone et al. (Int J Radiat Oncol Biol Phys 2007;69:1472-1477).
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Reference Values; Relative Biological Effectiveness; Risk | 2008 |
Relationship between isotope half-life and prostatic edema for optimal prostate dose coverage in permanent seed implants.
Topics: Algorithms; Brachytherapy; Cesium Radioisotopes; Edema; Equipment Design; Half-Life; Humans; Iodine Radioisotopes; Male; Palladium; Prostate; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiotherapy Planning, Computer-Assisted; Time Factors | 2008 |
Influence of Pro-Qura-generated plans on postimplant dosimetric quality: a review of a multi-institutional database.
Topics: Antineoplastic Protocols; Brachytherapy; Databases, Factual; Decision Support Systems, Clinical; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radiation Dosage; Radioisotopes; Radiology Information Systems; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Reference Standards; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
An EGSnrc Monte Carlo-calculated database of TG-43 parameters.
Topics: Brachytherapy; Databases, Factual; Humans; Iodine Radioisotopes; Male; Monte Carlo Method; Palladium; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
More accurate fitting of 125I and 103Pd radial dose functions.
Topics: Anisotropy; Brachytherapy; Humans; Iodine Radioisotopes; Male; Models, Theoretical; Monte Carlo Method; Palladium; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiotherapy Planning, Computer-Assisted | 2008 |
Effects of the time interval between prostate brachytherapy and postimplant dosimetric evaluation in community practice: analysis of the Pro-Qura database.
Topics: Brachytherapy; Databases, Factual; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radiation Dosage; Radiometry; Radiotherapy Dosage; Time Factors; Tomography, X-Ray Computed | 2008 |
Development of a spherical (125)i-brachytherapy seed for its application in the treatment of eye and prostate cancer.
Topics: Brachytherapy; Eye Neoplasms; Humans; Iodine Radioisotopes; Male; Microspheres; Palladium; Prostatic Neoplasms; Radiotherapy Dosage; Silver; Titanium | 2008 |
Synthesis, oxidant properties, and antitumoral effects of a heteroleptic palladium(II) complex of curcumin on human prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Curcumin; DNA Damage; Humans; Male; MAP Kinase Kinase 4; Oxidants; Palladium; Prostatic Neoplasms; Reactive Oxygen Species; Signal Transduction; Spectrophotometry, Ultraviolet | 2009 |
Determination of the prescription dose for biradionuclide permanent prostate brachytherapy.
Topics: Brachytherapy; Cell Survival; Cesium Radioisotopes; Edema; Humans; Iodine Radioisotopes; Male; Models, Statistical; Models, Theoretical; Palladium; Prostate; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage | 2008 |
Angle-dependent ultrasonic detection and imaging of two types of brachytherapy seeds using singular spectrum analysis.
Topics: Algorithms; Animals; Brachytherapy; Cattle; Computer Simulation; Gels; Humans; Iodine Radioisotopes; Male; Meat; Models, Biological; Palladium; Peritoneum; Phantoms, Imaging; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Signal Processing, Computer-Assisted; Ultrasonography | 2008 |
Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
Topics: Analysis of Variance; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biopsy; Brachytherapy; Flutamide; Follow-Up Studies; Goserelin; Humans; Iodine Radioisotopes; Leuprolide; Male; Nitriles; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Relative Biological Effectiveness; Tosyl Compounds; Treatment Failure | 2009 |
A detailed radiobiological and dosimetric analysis of biochemical outcomes in a case-control study of permanent prostate brachytherapy patients.
Topics: Aged; Biophysical Phenomena; Brachytherapy; Case-Control Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiobiology; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Treatment Failure | 2009 |
Evaluation of the dose distribution for prostate implants using various 125I and 103Pd sources.
Topics: Air; Algorithms; Brachytherapy; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results | 2009 |
Seed implant retention score predicts the risk of prolonged urinary retention after prostate brachytherapy.
Topics: Aged; Analysis of Variance; Androgen Antagonists; Brachytherapy; Humans; Iodine Radioisotopes; Male; Neoadjuvant Therapy; Organ Size; Palladium; Prostate; Prostatic Neoplasms; Radioisotopes; Risk Assessment; Urinary Catheterization; Urinary Retention | 2010 |
Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy.
Topics: Aged; Brachytherapy; Cardiovascular Diseases; Cause of Death; Cesium Radioisotopes; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Regression Analysis | 2010 |
Biologically effective dose (BED) correlation with biochemical control after low-dose rate prostate brachytherapy for clinically low-risk prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Palladium; Proportional Hazards Models; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Relative Biological Effectiveness; Retrospective Studies; ROC Curve | 2010 |
Dosimetric study of Cs-131, I-125, and Pd-103 seeds for permanent prostate brachytherapy.
Topics: Administration, Rectal; Brachytherapy; Cesium Radioisotopes; Equipment Design; Humans; Iodine Radioisotopes; Male; Needles; Palladium; Prostatic Neoplasms; Radioisotopes; Urinary Catheterization | 2009 |
Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer.
Topics: Age Factors; Analysis of Variance; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Regression Analysis; Relative Biological Effectiveness; Retrospective Studies; Treatment Outcome | 2010 |
Radiation protection of persons living close to patients with radioactive implants.
Topics: Brachytherapy; Caregivers; Humans; Iodine Radioisotopes; Male; Palladium; Patient Discharge; Prostatic Neoplasms; Protective Clothing; Radiation Dosage; Radiation Injuries; Radiation Protection; Radioisotopes; Radiometry; Radiotherapy Dosage | 2010 |
Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer.
Topics: Aged; Analysis of Variance; Brachytherapy; Erectile Dysfunction; Follow-Up Studies; Humans; Iodine Radioisotopes; Lymph Node Excision; Male; Middle Aged; Palladium; Pelvis; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Salvage Therapy; Treatment Outcome; Urination Disorders | 2010 |
Response to "Comment on 'AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137'" [Med. Phys. 36, 5310-5322 (2009)].
Topics: Algorithms; Brachytherapy; Cesium Radioisotopes; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy Dosage; Time Factors; Tomography, X-Ray Computed | 2010 |
Comparison of intraoperatively built custom linked seeds versus loose seed gun applicator technique using real-time intraoperative planning for permanent prostate brachytherapy.
Topics: Aged; Anesthesia; Brachytherapy; Computer Systems; Equipment Design; Humans; Intraoperative Period; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Statistics, Nonparametric; Time Factors | 2011 |
Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Topics: Adipose Tissue; Algorithms; Biophysical Phenomena; Brachytherapy; Breast; Breast Neoplasms; Cesium Radioisotopes; Female; Humans; Iodine Radioisotopes; Male; Monte Carlo Method; Palladium; Prostate; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2010 |
Dosimetric parameters of the new design (103)Pd brachytherapy source based on Monte Carlo study.
Topics: Anisotropy; Brachytherapy; Humans; Male; Monte Carlo Method; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy, Computer-Assisted | 2012 |
Serum testosterone kinetics after brachytherapy for clinically localized prostate cancer.
Topics: Analysis of Variance; Brachytherapy; Humans; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Testosterone; Time Factors | 2012 |
Moving toward focal therapy in prostate cancer: dual-isotope permanent seed implants as a possible solution.
Topics: Brachytherapy; Cesium Radioisotopes; Feasibility Studies; Half-Life; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Models, Biological; Organ Size; Organs at Risk; Palladium; Prostate; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Relative Biological Effectiveness; Retrospective Studies; Tumor Burden; Ultrasonography; Urethra | 2011 |
Comparison of CT and MR-CT fusion for prostate post-implant dosimetry.
Topics: Brachytherapy; Humans; Magnetic Resonance Imaging; Male; Observer Variation; Palladium; Prostate; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy Dosage; Reproducibility of Results; Tomography, X-Ray Computed | 2012 |
Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancer.
Topics: Aged; Androgen Antagonists; Brachytherapy; Cause of Death; Disease-Free Survival; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Regression Analysis; Risk Assessment | 2012 |
Titanocene-phosphine derivatives as precursors to cytotoxic heterometallic TiAu2 and TiM (M = Pd, Pt) compounds. Studies of their interactions with DNA.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Circular Dichroism; DNA; Female; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Male; Models, Molecular; Nucleic Acid Conformation; Organometallic Compounds; Palladium; Phosphines; Platinum; Prostatic Neoplasms; Spectrophotometry, Infrared; Structure-Activity Relationship; Titanium; Uterine Cervical Neoplasms | 2011 |
PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure.
Topics: Adenocarcinoma; Aged; Analysis of Variance; Brachytherapy; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Intensity-Modulated; Reference Values; Retrospective Studies; Risk | 2012 |
Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
Topics: Aged; Aged, 80 and over; Brachytherapy; Chi-Square Distribution; Combined Modality Therapy; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Quality of Life; Radioisotopes; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Rectal Diseases; Regression Analysis; Retrospective Studies; Surveys and Questionnaires; Urination Disorders | 2012 |
The impact of diabetes mellitus on survival in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy.
Topics: Age Factors; Aged; Brachytherapy; Diabetes Complications; Disease-Free Survival; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoplasm Grading; Palladium; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms | 2012 |
Predictors of metastatic disease after prostate brachytherapy.
Topics: Analysis of Variance; Androgen Antagonists; Brachytherapy; Combined Modality Therapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Retrospective Studies | 2012 |
Twelve-month prostate-specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed brachytherapy.
Topics: Aged; Analysis of Variance; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Time Factors | 2012 |
Prognostic importance of small prostate size in men receiving definitive prostate brachytherapy.
Topics: Aged; Analysis of Variance; Androgen Antagonists; Brachytherapy; Cause of Death; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Organ Size; Palladium; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radioisotopes | 2012 |
Role of isotope selection in long-term outcomes in patients with intermediate-risk prostate cancer treated with a combination of external beam radiotherapy and low-dose-rate interstitial brachytherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Disease-Free Survival; Hormones; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Palladium; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Intensity-Modulated; Risk Factors | 2012 |
Gleason 7 prostate cancer treated with low-dose-rate brachytherapy: lack of impact of primary Gleason pattern on biochemical failure.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Brachytherapy; Chemotherapy, Adjuvant; Follow-Up Studies; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Neoplasm Grading; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Treatment Failure | 2012 |
Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer.
Topics: Aged; Biopsy; Brachytherapy; Disease-Free Survival; Feasibility Studies; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Organs at Risk; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Rectum; Salvage Therapy; Urethra | 2013 |
Long-term potency preservation following brachytherapy for prostate cancer.
Topics: Adult; Age Factors; Aged; Androgen Antagonists; Antineoplastic Agents; Brachytherapy; Combined Modality Therapy; Erectile Dysfunction; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Palladium; Penile Erection; Phosphodiesterase Inhibitors; Prospective Studies; Prostatic Neoplasms; Radioisotopes | 2012 |
Carbophilic 3-component cascades: access to complex bioactive cyclopropyl diindolylmethanes.
Topics: Antineoplastic Agents; Catalysis; Cell Line; Cyclopropanes; Humans; Indoles; Male; Palladium; Prostatic Neoplasms; Stereoisomerism | 2013 |
Dosimetric consideration of transient volume enlargement induced by edema in prostate brachytherapy seed implants.
Topics: Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Seeds; Tomography, X-Ray Computed | 2013 |
Dosimetric comparison between bone marrow sparing intensity-modulated radiation therapy and conventional techniques in the treatment of cervical cancer: a retrospective study.
Topics: Bone Marrow; Brachytherapy; Humans; Iodine Radioisotopes; Palladium; Prostatic Neoplasms; Radiotherapy Dosage; Retrospective Studies; Uterine Cervical Neoplasms | 2013 |
Prostate brachytherapy seed migration to a coronary artery found during angiography.
Topics: Aged; Brachytherapy; Coronary Angiography; Coronary Vessels; Foreign-Body Migration; Humans; Male; Palladium; Prostatic Neoplasms; Radioisotopes | 2002 |
A novel approach for the adsorption of iodine-125 on silver wire as matrix for brachytherapy source for the treatment of eye and prostate cancer.
Topics: Adsorption; Brachytherapy; Eye Neoplasms; Humans; Hydrogen-Ion Concentration; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Silver; Titanium | 2002 |
The effects of edema on urethral dose following palladium-103 prostate brachytherapy.
Topics: Brachytherapy; Dose-Response Relationship, Radiation; Edema; Humans; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Time Factors; Tomography, X-Ray Computed; Urethra; Urethral Diseases | 2002 |
Perioperative costs and charges of prostate brachytherapy and prostatectomy.
Topics: Adenocarcinoma; Brachytherapy; Fees and Charges; Fees, Medical; Health Care Costs; Hospital Charges; Hospital Costs; Humans; Male; Palladium; Prostatectomy; Prostatic Neoplasms; Radiation Oncology; Radioisotopes; Treatment Outcome | 2002 |
Longitudinal comparison of sexual function after 3-dimensional conformal radiation therapy or prostate brachytherapy.
Topics: Aged; Brachytherapy; Erectile Dysfunction; Humans; Longitudinal Studies; Male; Middle Aged; Palladium; Patient Satisfaction; Penile Erection; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal | 2002 |
Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase.
Topics: Acid Phosphatase; Aged; Biomarkers, Tumor; Brachytherapy; Carcinoma; Humans; Male; Middle Aged; Palladium; Prognosis; Prostatic Neoplasms; Protein Tyrosine Phosphatases; Radioisotopes; Time Factors; Treatment Outcome | 2003 |
[Technique of intraoperative planning in prostatic brachytherapy with permanent implants of 125I or 103Pd].
Topics: Brachytherapy; Humans; Intraoperative Care; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes | 2002 |
Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
Topics: Brachytherapy; Computer Simulation; Databases, Factual; Humans; Iodine Radioisotopes; Male; Models, Biological; Models, Statistical; Monte Carlo Method; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Sensitivity and Specificity; Software; United States | 2003 |
Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications.
Topics: Age Factors; Aged; Aged, 80 and over; Brachytherapy; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Recurrence | 2003 |
Long-term urinary quality of life after permanent prostate brachytherapy.
Topics: Aged; Analysis of Variance; Brachytherapy; Case-Control Studies; Follow-Up Studies; Humans; Iodine Radioisotopes; Linear Models; Male; Middle Aged; Palladium; Prostatic Neoplasms; Quality of Life; Radioisotopes; Urinary Incontinence; Urinary Retention; Urination Disorders | 2003 |
Radiation exposure to family and household members after prostate brachytherapy.
Topics: Brachytherapy; Family; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radiation Dosage; Radiation Monitoring; Radioisotopes; Spouses | 2003 |
Salvage reimplantation in patient with local recurrent prostate carcinoma after brachytherapy with three dimensional computed tomography-guided permanent pararectal implant.
Topics: Aged; Brachytherapy; Humans; Imaging, Three-Dimensional; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioisotopes; Recurrence; Salvage Therapy; Time Factors; Tomography, X-Ray Computed | 2003 |
Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma.
Topics: Adenocarcinoma; Aged; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunodetection; Radioisotopes; Radiotherapy Dosage; Time Factors | 2003 |
Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations.
Topics: Cell Survival; Computer Simulation; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Models, Biological; Palladium; Prostate; Prostatic Neoplasms; Radiation Protection; Radioisotopes; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Relative Biological Effectiveness; Risk Assessment; Treatment Outcome; Urethra | 2003 |
Extracapsular radiation dose distribution after permanent prostate brachytherapy.
Topics: Aged; Brachytherapy; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Planning, Computer-Assisted | 2003 |
Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Analysis of Variance; Androgen Antagonists; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Palladium; Patient Selection; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Risk Assessment; Treatment Failure | 2003 |
Prostate implant nomograms for the North American Scientific 103Pd seed.
Topics: Brachytherapy; Humans; Male; Palladium; Prostatic Neoplasms; Radioisotopes | 2003 |
Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience.
Topics: Brachytherapy; Cohort Studies; Disease-Free Survival; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Time Factors; Treatment Failure | 2003 |
How low is the alpha/beta ratio for prostate cancer?
Topics: Brachytherapy; DNA Repair; Edema; Humans; Iodine Radioisotopes; Linear Models; Male; Palladium; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Reference Values; Relative Biological Effectiveness | 2003 |
The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Brachytherapy; Combined Modality Therapy; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Conformal | 2003 |
High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
Topics: Adenocarcinoma; Aged; Brachytherapy; Follow-Up Studies; Humans; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiotherapy Dosage | 2004 |
Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy.
Topics: Aged; Algorithms; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Smoking | 2004 |
Defining the appropriate patient population for primary brachytherapy for localized prostate cancer: work in progress.
Topics: Adenocarcinoma; Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Risk Factors | 2004 |
Prediction of genitourinary tract morbidity after brachytherapy for prostate adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Brachytherapy; Dilatation; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Palladium; Prostatic Neoplasms; Radioisotopes; Retrospective Studies; Risk Factors; Transurethral Resection of Prostate; Urethral Stricture; Urinary Catheterization; Urinary Incontinence; Urodynamics | 2004 |
Combination conformal radiotherapy and radioimmunoguided transperineal 103Pd implantation for patients with intermediate and unfavorable risk prostate adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Combined Modality Therapy; Humans; Indium Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioimmunodetection; Radioisotopes; Radiotherapy, Conformal; Risk Factors; Survival Analysis; Treatment Outcome | 2003 |
Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
Topics: Brachytherapy; Computer Systems; Dose-Response Relationship, Radiation; Humans; Intraoperative Care; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Prostheses and Implants; Radioisotopes; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Interventional; Urethra | 2003 |
The effect of isotope selection on the prostate-specific antigen response in patients treated with permanent prostate brachytherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; New York; Palladium; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Time Factors; Treatment Outcome | 2003 |
Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
Topics: Aged; Aged, 80 and over; Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Phantoms, Imaging; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2004 |
In regards to Wallner et al: (125)I versus (103)PD for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial (Int J Radiat Oncol Biol Phys 2003;57:1297-1303).
Topics: Aged; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Prospective Studies; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Time Factors | 2004 |
[PSA bounce phenomenon after transperineal interstitial permanent prostate brachytherapy for localized prostate cancer].
Topics: Aged; Biomarkers, Tumor; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Time Factors | 2004 |
Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors.
Topics: Brachytherapy; Cohort Studies; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Treatment Outcome | 2004 |
The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy.
Topics: Aged; Antineoplastic Agents, Hormonal; Brachytherapy; Cohort Studies; Combined Modality Therapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Retrospective Studies; Transurethral Resection of Prostate; Urinary Catheterization; Urinary Retention | 2004 |
Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy.
Topics: Analysis of Variance; Androgen Antagonists; Antineoplastic Agents, Hormonal; Brachytherapy; Catheterization; Gonadotropin-Releasing Hormone; Humans; Iodine Radioisotopes; Male; Neoadjuvant Therapy; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Regression Analysis; ROC Curve; Urethra; Urinary Bladder Neck Obstruction | 2004 |
Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator.
Topics: Adenocarcinoma; Brachytherapy; Foreign-Body Migration; Humans; Iodine Radioisotopes; Lung; Male; Palladium; Pelvis; Prostatic Neoplasms; Pulmonary Embolism; Radiography; Radioisotopes | 2004 |
Selective identification of different brachytherapy sources, ferromagnetic seeds, and fiducials in the prostate using an automated seed sorting algorithm.
Topics: Aged; Algorithms; Brachytherapy; Ferric Compounds; Humans; Iridium Radioisotopes; Male; Palladium; Pelvis; Prostate; Prostatic Neoplasms; Radioisotopes; Salvage Therapy; Tomography, X-Ray Computed | 2004 |
Transperineal interstitial permanent prostate brachytherapy for Japanese prostate cancer patients in Hawaii.
Topics: Aged; Aged, 80 and over; Asian People; Brachytherapy; Follow-Up Studies; Hawaii; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioisotopes; Treatment Outcome | 2004 |
Does prior transurethral resection of prostate compromise brachytherapy quality: a dosimetric analysis.
Topics: Brachytherapy; Contraindications; Humans; Iodine Radioisotopes; Male; Palladium; Prostate; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Retrospective Studies; Transurethral Resection of Prostate; Ultrasonography | 2004 |
Combined external beam radiotherapy and Pd-103 brachytherapy boost improves biochemical failure free survival in patients with clinically localized prostate cancer: results of a matched pair analysis.
Topics: Aged; Brachytherapy; Dose-Response Relationship, Radiation; Humans; Male; Matched-Pair Analysis; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Retrospective Studies; Survival Analysis; Treatment Outcome | 2005 |
New data on the value of alpha/beta--evidence mounts that it is low.
Topics: Algorithms; Dose Fractionation, Radiation; Humans; Iodine Radioisotopes; Male; Meta-Analysis as Topic; Models, Biological; Palladium; Prostatic Neoplasms; Radioisotopes | 2004 |
Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer.
Topics: Adenocarcinoma; Adult; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Life Tables; Male; Middle Aged; Neoplasm Invasiveness; Palladium; Proportional Hazards Models; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Radiotherapy, High-Energy; Risk; Treatment Outcome | 2004 |
Dosimetric characteristics of the new RadioCoil 103Pd wire line source for use in permanent brachytherapy implants.
Topics: Body Burden; Brachytherapy; Equipment Design; Equipment Failure Analysis; Humans; Male; Models, Biological; Monte Carlo Method; Organ Specificity; Palladium; Prostatic Neoplasms; Prostheses and Implants; Radioisotopes; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Relative Biological Effectiveness | 2004 |
MR and CT image fusion for postimplant analysis in permanent prostate seed implants.
Topics: Aged; Algorithms; Brachytherapy; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Reproducibility of Results; Tomography, X-Ray Computed | 2004 |
Dosimetric characterization of radioactive sources employed in prostate cancer therapy.
Topics: Brachytherapy; Computer Simulation; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy, Computer-Assisted | 2004 |
Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy.
Topics: Aged; Brachytherapy; Cause of Death; Epidemiologic Methods; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes | 2005 |
Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy.
Topics: Analysis of Variance; Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Urinary Catheterization; Urinary Retention | 2005 |
Prostate brachytherapy as monotherapy: Are there gaps, holes, and islands in the argument? In regard to Wallner et al. (Int J Radiat Oncol Biol Phys 2003;57:1297-1303).
Topics: Humans; Iodine Radioisotopes; Male; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes | 2005 |
[The recommendations of the International Commission on Radiological Protection (ICRP) for high-dose-rate brachytherapy and for permanent prostatic implants].
Topics: Adult; Brachytherapy; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radiation Injuries; Radiation Protection; Radioisotopes; Radiotherapy Dosage | 2004 |
103Pd brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer: a 12-year experience from a single group practice.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Humans; Male; Middle Aged; Palladium; Prostatectomy; Prostatic Neoplasms; Radioisotopes; Retrospective Studies; Time Factors | 2005 |
The effect on erectile function of 103palladium implantation for localized prostate cancer.
Topics: Aged; Aged, 80 and over; Brachytherapy; Erectile Dysfunction; Humans; Male; Middle Aged; Multivariate Analysis; Palladium; Prospective Studies; Prostatic Neoplasms; Radioisotopes | 2005 |
Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Agents, Hormonal; Brachytherapy; Combined Modality Therapy; Enzyme Inhibitors; Finasteride; Humans; Leuprolide; Male; Neoadjuvant Therapy; Neoplasm Staging; Palladium; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Risk Factors; Survival Rate; Testosterone; Treatment Outcome; Ultrasonography, Interventional | 2005 |
Tumor control outcomes of patients treated with trimodality therapy for locally advanced prostate cancer.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Brachytherapy; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Humans; Leuprolide; Male; Middle Aged; Neoadjuvant Therapy; Palladium; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes | 2005 |
Determination of dosimetric characteristics of OptiSeed(TM) a plastic brachytherapy (103)Pd source.
Topics: Brachytherapy; Computer Simulation; Humans; Male; Monte Carlo Method; Palladium; Prostatic Neoplasms; Radiometry; Radiotherapy Dosage | 2005 |
Acute urinary morbidity following I-125 prostate brachytherapy.
Topics: Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Japan; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radiopharmaceuticals; Urinary Tract; Urination Disorders | 2005 |
Treatment planning consideration for prostate implants with the new linear RadioCoil 103Pd brachytherapy source.
Topics: Brachytherapy; Equipment Failure Analysis; Humans; Male; Palladium; Prostatic Neoplasms; Prostheses and Implants; Radioisotopes; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
Topics: Anisotropy; Body Burden; Brachytherapy; Computer Simulation; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Models, Biological; Organ Specificity; Palladium; Prostatic Neoplasms; Prostheses and Implants; Radioisotopes; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Relative Biological Effectiveness | 2005 |
The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy.
Topics: Aged; Brachytherapy; Humans; Iodine Radioisotopes; Linear Models; Male; Palladium; Prostate; Prostatic Neoplasms; Radioisotopes; Urinary Bladder Neck Obstruction; Urinary Catheterization | 2006 |
Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results.
Topics: Age Factors; Aged; Biopsy; Brachytherapy; Dose-Response Relationship, Radiation; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Regression Analysis; Relative Biological Effectiveness; Time Factors | 2006 |
Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy.
Topics: Aged; Analysis of Variance; Brachytherapy; Catheterization; Cohort Studies; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Severity of Illness Index; Transurethral Resection of Prostate; Urinary Retention | 2006 |
Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
Topics: Brachytherapy; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Observer Variation; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy Dosage; Treatment Outcome; Tumor Burden; Ultrasound, High-Intensity Focused, Transrectal; Urethral Neoplasms | 2005 |
MCPI: a sub-minute Monte Carlo dose calculation engine for prostate implants.
Topics: Benchmarking; Biophysical Phenomena; Biophysics; Brachytherapy; Humans; Iodine Radioisotopes; Male; Monte Carlo Method; Palladium; Phantoms, Imaging; Prostatic Neoplasms; Radioisotopes; Radiotherapy Planning, Computer-Assisted | 2005 |
Radiation exposure after permanent prostate brachytherapy.
Topics: Brachytherapy; Drug Therapy, Combination; Environmental Exposure; Family; Humans; Iodine Radioisotopes; Italy; Male; Palladium; Patient Education as Topic; Prostatic Neoplasms; Radiation Monitoring; Radiation Protection; Radioisotopes; Retrospective Studies | 2006 |
Role of external beam radiotherapy with low-dose-rate brachytherapy in treatment of prostate cancer.
Topics: Aged; Biomarkers, Tumor; Brachytherapy; Disease Progression; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Retrospective Studies; Survival Analysis | 2006 |
Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage | 2006 |
Brachytherapy in men aged < or = 54 years with clinically localized prostate cancer.
Topics: Brachytherapy; Disease-Free Survival; Humans; Iodine Radioisotopes; Isotopes; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms | 2006 |
15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Brachytherapy; Cohort Studies; Disease-Free Survival; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Adjuvant | 2007 |
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.
Topics: Brachytherapy; Disease-Free Survival; Humans; Iodine Radioisotopes; Male; Multivariate Analysis; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Treatment Outcome | 2007 |
Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension.
Topics: Aged; Biopsy, Needle; Brachytherapy; Carcinoma; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Palladium; Probability; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Risk Assessment; Survival Analysis; Time Factors; Treatment Outcome | 2007 |
A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.
Topics: Aged; Analysis of Variance; Ataxia Telangiectasia Mutated Proteins; Brachytherapy; Cell Cycle Proteins; DNA-Binding Proteins; Dose-Response Relationship, Radiation; Erectile Dysfunction; Gastrointestinal Hemorrhage; Humans; Iodine Radioisotopes; Male; Middle Aged; Mutation, Missense; Palladium; Proctitis; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Radioisotopes; Rectal Diseases; Rectum; Tumor Suppressor Proteins | 2007 |
Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features.
Topics: Aged; Aged, 80 and over; Biopsy, Needle; Brachytherapy; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, High-Energy; Risk Assessment; Survival Rate; Time Factors; Treatment Outcome | 2007 |
PSA spikes not always cause for alarm.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes | 2007 |
Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Reference Values; Relative Biological Effectiveness; Risk | 2007 |
Intraoperative ultrasound-fluoroscopy fusion can enhance prostate brachytherapy quality.
Topics: Algorithms; Brachytherapy; Fluoroscopy; Humans; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Ultrasonography | 2007 |
Radioactive "seed" implants may rival surgery for low-risk prostate cancer patients.
Topics: Bias; Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatectomy; Prostatic Neoplasms; Quality of Life; Radioisotopes; Radiotherapy Dosage; Risk Factors; Survival Rate; Treatment Outcome | 2007 |
Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy.
Topics: Brachytherapy; Humans; Intraoperative Period; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy Dosage; Rectum; Tomography, X-Ray Computed; Ultrasonography; Urethra | 2008 |
Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapy.
Topics: Acid Phosphatase; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Humans; Male; Middle Aged; Multivariate Analysis; Palladium; Predictive Value of Tests; Proportional Hazards Models; Prostatic Neoplasms; Protein Tyrosine Phosphatases; Radioisotopes; Radiotherapy Dosage; Retrospective Studies | 2008 |
Laparoscopic pelvic lymph node dissection combined with real-time interactive transrectal ultrasound guided transperineal radioactive seed implantation of the prostate.
Topics: Aged; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Laparoscopy; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Staging; Palladium; Pelvis; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Time Factors; Treatment Failure; Ultrasonography | 1995 |
Dose effects of seeds placement deviations from pre-planned positions in ultrasound guided prostate implants.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostate; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Software; Ultrasonography, Interventional | 1994 |
Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration.
Topics: Aged; Aged, 80 and over; Brachytherapy; Follow-Up Studies; Foreign-Body Migration; Humans; Lung; Male; Middle Aged; Neoplasm Staging; Palladium; Prostatic Neoplasms; Urination Disorders | 1995 |
Verification of manufacturer-supplied 125I and 103Pd air-kerma strengths.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Quality Assurance, Health Care; Radioisotopes | 1995 |
103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Brachytherapy; Humans; Male; Middle Aged; Neoplasm Staging; Palladium; Penile Erection; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes | 1996 |
The use of transrectal ultrasound placement of radioactive seeds for the definitive treatment of prostate cancer.
Topics: Adenocarcinoma; Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Ultrasonography | 1996 |
A genetic algorithm for the optimization of prostate implants.
Topics: Algorithms; Biophysical Phenomena; Biophysics; Brachytherapy; Humans; Male; Models, Biological; Models, Genetic; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Planning, Computer-Assisted | 1996 |
Brachytherapy (seed implantation) for clinically localized prostate cancer.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Computer-Assisted; Ultrasonography | 1997 |
Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer.
Topics: Biopsy; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Neoplasm Proteins; Neoplasm Staging; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes | 1997 |
Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection.
Topics: Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Palladium; Penile Erection; Prostatic Neoplasms; Radioisotopes; Rectum; Urinary Incontinence | 1997 |
Brachytherapy for prostate cancer: real-time three-dimensional interactive seed implantation.
Topics: Biopsy; Brachytherapy; Carcinoma; Cystitis; Disease-Free Survival; Follow-Up Studies; Humans; Indium Radioisotopes; Laparoscopy; Lymph Node Excision; Male; Neoplasm Staging; Palladium; Penile Erection; Proctitis; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiopharmaceuticals; Safety; Ultrasonography, Interventional; Urinary Incontinence; Urinary Retention | 1995 |
Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate.
Topics: Brachytherapy; Carcinoma; Foreign-Body Migration; Humans; Male; Palladium; Prostatic Neoplasms; Pulmonary Embolism; Radiography; Radioisotopes | 1997 |
Regarding, Dattoli, Wallner, Sorace, Koval, Cash, Acosta, Brown, Etheridge, Binder, Brunelle, Kirwan, Sanchez, Stein, and Wasserman IJROBP 35(5):875-879; 1996.
Topics: Brachytherapy; Data Interpretation, Statistical; Humans; Male; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy | 1997 |
A survey of physics and dosimetry practice of permanent prostate brachytherapy in the United States.
Topics: Brachytherapy; Health Care Surveys; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Quality Assurance, Health Care; Radioisotopes; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; United States | 1998 |
Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
Topics: Adenocarcinoma; Brachytherapy; Dose-Response Relationship, Radiation; Edema; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 1998 |
Outpatient ultrasound-guided palladium 103 brachytherapy for localized adenocarcinoma of the prostate: a preliminary report of 434 patients.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Ambulatory Care; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brachytherapy; Chemotherapy, Adjuvant; Flutamide; Follow-Up Studies; Humans; Leuprolide; Male; Middle Aged; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Treatment Outcome; Ultrasonography, Interventional | 1998 |
Corrosion analysis of NiCu and PdCo thermal seed alloys used as interstitial hyperthermia implants.
Topics: Alloys; Animals; Biocompatible Materials; Cobalt; Copper; Corrosion; Electrochemistry; Hyperthermia, Induced; Isotonic Solutions; Male; Microscopy, Electron, Scanning; Nickel; Palladium; Prostatic Neoplasms; Prostheses and Implants; Ringer's Solution | 1997 |
Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition.
Topics: Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radiography; Radiotherapy Dosage; Time Factors | 1998 |
Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy.
Topics: Aged; Brachytherapy; Carcinoma; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Time Factors; Treatment Outcome; Ultrasonography | 1998 |
Radioactive seeds for prostate cancer.
Topics: Brachytherapy; Erectile Dysfunction; Humans; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Palladium; Prostatic Neoplasms; Radioisotopes; Urinary Incontinence | 1998 |
A calculation of the relative biological effectiveness of 125I and 103Pd brachytherapy sources using the concept of proximity function.
Topics: Brachytherapy; Cobalt Radioisotopes; Humans; Iodine Radioisotopes; Male; Neoplasms; Palladium; Phantoms, Imaging; Probability; Prostatic Neoplasms; Radioisotopes; Water | 1998 |
Reduction of radioactive seed embolization to the lung following prostate brachytherapy.
Topics: Brachytherapy; Foreign-Body Migration; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Pulmonary Embolism; Radioisotopes; Radiopharmaceuticals | 1998 |
A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
Topics: Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Models, Biological; Movement; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Time Factors; Tomography, X-Ray Computed | 1999 |
103Pd loaded cartridge air kerma strength verification.
Topics: Brachytherapy; Calibration; Humans; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy Dosage | 1999 |
Rectal dosimetric analysis following prostate brachytherapy.
Topics: Brachytherapy; Cohort Studies; Humans; Iodine Radioisotopes; Male; Palladium; Proctitis; Prostatic Neoplasms; Radiation Dosage; Radiation Tolerance; Radioisotopes; Radiopharmaceuticals; Rectum; Retrospective Studies; Tomography, X-Ray Computed | 1999 |
Potential role of various dosimetric quality indicators in prostate brachytherapy.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Retrospective Studies; Ultrasonography, Interventional | 1999 |
The impact of edema on planning 125I and 103Pd prostate implants.
Topics: Brachytherapy; Dose-Response Relationship, Radiation; Edema; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Time Factors | 1999 |
Intraoperative optimized inverse planning for prostate brachytherapy: early experience.
Topics: Algorithms; Brachytherapy; Decision Theory; Feasibility Studies; Humans; Intraoperative Period; Iodine Radioisotopes; Male; Palladium; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Ultrasonography | 1999 |
The effect of androgen deprivation on the early changes in prostate volume following transperineal ultrasound guided interstitial therapy for localized carcinoma of the prostate.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Brachytherapy; Combined Modality Therapy; Dose-Response Relationship, Radiation; Goserelin; Humans; Iodine Radioisotopes; Leuprolide; Male; Palladium; Prostatic Neoplasms; Radiopharmaceuticals; Ultrasonography, Interventional | 1999 |
Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.
Topics: Aged; Aged, 80 and over; Area Under Curve; Brachytherapy; Follow-Up Studies; Hematuria; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Ultrasonography, Interventional; Urination Disorders | 1999 |
Does prostate brachytherapy treat the seminal vesicles? A dose-volume histogram analysis of seminal vesicles in patients undergoing combined PD-103 prostate implantation and external beam irradiation.
Topics: Brachytherapy; Humans; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Seminal Vesicles; Tomography, X-Ray Computed | 1999 |
Isotope selection for patients undergoing prostate brachytherapy.
Topics: Analysis of Variance; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Matched-Pair Analysis; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Retrospective Studies; Treatment Outcome | 1999 |
Radiation safety parameters following prostate brachytherapy.
Topics: Brachytherapy; Carcinoma; Environmental Exposure; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Palladium; Prostatic Neoplasms; Radioactivity; Radioisotopes | 1999 |
Treatment planning considerations and quality assurance for CT-guided transischiorectal implantation of the prostate.
Topics: Biophysical Phenomena; Biophysics; Brachytherapy; Evaluation Studies as Topic; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Quality Assurance, Health Care; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 1999 |
103Pd brachytherapy dose prescription.
Topics: Biophysical Phenomena; Biophysics; Brachytherapy; Humans; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Reference Standards | 1999 |
Effect of post-implant edema on the rectal dose in prostate brachytherapy.
Topics: Brachytherapy; Cohort Studies; Edema; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Diseases; Prostatic Neoplasms; Radiation Dosage; Radiopharmaceuticals; Rectum; Tomography, X-Ray Computed | 1999 |
Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Brachytherapy; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Proteins; Neoplasm Staging; Palladium; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Treatment Failure | 1999 |
Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
Topics: Brachytherapy; Edema; Half-Life; Humans; Iodine Radioisotopes; Male; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Time Factors | 1999 |
Long-term complications with prostate implants: iodine-125 vs. palladium-103.
Topics: Actuarial Analysis; Brachytherapy; Cell Death; Follow-Up Studies; Forecasting; Humans; Iodine Radioisotopes; Longitudinal Studies; Male; Models, Biological; Neoplasm Staging; Palladium; Probability; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Relative Biological Effectiveness; Retrospective Studies; Treatment Outcome | 1999 |
Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
Topics: Algorithms; Brachytherapy; Cell Hypoxia; Cell Survival; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Linear Models; Male; Models, Biological; Palladium; Prognosis; Prostatic Neoplasms; Radiation Tolerance; Radiotherapy; Radiotherapy Planning, Computer-Assisted; Risk Factors; Tumor Cells, Cultured | 2000 |
Seed fixity in the prostate/periprostatic region following brachytherapy.
Topics: Aged; Brachytherapy; Foreign-Body Migration; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Pulmonary Embolism; Radioisotopes | 2000 |
Toward a statistically relevant calibration end point for prostate seed implants.
Topics: Biophysical Phenomena; Biophysics; Brachytherapy; Computer Simulation; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Quality Control; Radioisotopes; Radiotherapy Planning, Computer-Assisted | 2000 |
Palladium-103 brachytherapy for prostate carcinoma.
Topics: Aged; Analysis of Variance; Brachytherapy; Cohort Studies; Disease-Free Survival; Follow-Up Studies; Half-Life; Humans; Male; Neoplasm Staging; Palladium; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Treatment Failure; Ultrasonography, Interventional | 2000 |
Temporal resolution of urinary morbidity following prostate brachytherapy.
Topics: Adrenergic alpha-Antagonists; Aged; Brachytherapy; Carcinoma; Humans; Iodine Radioisotopes; Male; Multivariate Analysis; Palladium; Prostatic Neoplasms; Urinary Catheterization; Urination Disorders | 2000 |
Brachytherapy in patients with small prostate glands.
Topics: Brachytherapy; Carcinoma; Endosonography; Humans; Iodine Radioisotopes; Male; Palladium; Prostate; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rectum; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2000 |
A nomogram to compensate for intraoperative prostate edema during transperineal brachytherapy.
Topics: Adenocarcinoma; Aged; Algorithms; Brachytherapy; Edema; Endosonography; Humans; Intraoperative Complications; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Palladium; Perineum; Prospective Studies; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiotherapy Dosage; Rectum; Tomography, X-Ray Computed | 2000 |
Evolution of techniques for ultrasound-guided palladium 103 brachytherapy in 950 patients with prostate cancer.
Topics: Adenocarcinoma; Aged; Biopsy; Brachytherapy; Dose-Response Relationship, Radiation; Evaluation Studies as Topic; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Palladium; Perineum; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Retrospective Studies; Treatment Outcome; Ultrasonography | 2000 |
Use of image coregistration in salvage prostate brachytherapy.
Topics: Algorithms; Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Salvage Therapy; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Iodine-125 vs. palladium-103: long-term complications.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes | 2000 |
Dosimetric and volumetric criteria for selecting a source activity and a source type ((125)I or (103)Pd) in the presence of irregular seed placement in permanent prostate implants.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Physical Phenomena; Physics; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2000 |
Dosimetric effects of needle divergence in prostate seed implant using 125I and 103Pd radioactive seeds.
Topics: Biophysical Phenomena; Biophysics; Brachytherapy; Humans; Iodine Radioisotopes; Male; Models, Theoretical; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Planning, Computer-Assisted | 2000 |
Isotope choice and the effect of edema on prostate brachytherapy dosimetry.
Topics: Biophysical Phenomena; Biophysics; Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Planning, Computer-Assisted | 2000 |
Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
Topics: Anisotropy; Biophysical Phenomena; Biophysics; Brachytherapy; Humans; Male; Monte Carlo Method; Palladium; Phantoms, Imaging; Prostatic Neoplasms; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Thermoluminescent Dosimetry | 2000 |
Monte Carlo calculations and experimental measurements of dosimetry parameters of a new 103Pd source.
Topics: Anisotropy; Biophysical Phenomena; Biophysics; Brachytherapy; Humans; Male; Monte Carlo Method; Palladium; Photons; Prostatic Neoplasms; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Water | 2000 |
Brachytherapy for prostate cancer: summary of American Brachytherapy Society recommendations.
Topics: Brachytherapy; Follow-Up Studies; Humans; Intraoperative Care; Iodine Radioisotopes; Male; Palladium; Postoperative Care; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2000 |
Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
Topics: Adenocarcinoma; Algorithms; Brachytherapy; Cell Division; Cell Survival; Dose-Response Relationship, Radiation; Half-Life; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Therapeutic Equivalency; Time Factors | 2000 |
Transient elevation of serum prostate-specific antigen following (125)I/(103)Pd brachytherapy for localized prostate cancer.
Topics: Brachytherapy; Chi-Square Distribution; Humans; Iodine Radioisotopes; Male; Palladium; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes | 2000 |
Dosimetric effects of edema in permanent prostate seed implants: a rigorous solution.
Topics: Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Models, Biological; Palladium; Physical Phenomena; Physics; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage | 2000 |
Improvement of transperineal implant dosimetry by intraoperative cystoscopic confirmation of prostate anatomy.
Topics: Brachytherapy; Cystoscopy; Humans; Intraoperative Care; Iodine Radioisotopes; Male; Palladium; Prostate; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage | 2000 |
Minimally invasive treatment for localized adenocarcinoma of the prostate: review of 1048 patients treated with ultrasound-guided palladium-103 brachytherapy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Biopsy; Brachytherapy; Combined Modality Therapy; Flutamide; Humans; Leuprolide; Male; Middle Aged; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Ultrasonography | 2000 |
Biopsy results after real-time ultrasound-guided transperineal implants for stage T1-T2 prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Biopsy; Brachytherapy; Combined Modality Therapy; Computer Systems; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Perineum; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes | 2000 |
Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: results from a single practice.
Topics: Aged; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Retrospective Studies; Risk Factors | 2000 |
What is the T(pot) for prostate cancer? Radiobiological implications of the equivalent outcome with (125)I or (103)Pd.
Topics: Algorithms; Cell Survival; Humans; Iodine Radioisotopes; Linear Models; Male; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiobiology; Radioisotopes; Relative Biological Effectiveness; Time Factors; Tumor Cells, Cultured | 2000 |
Scatter radiation from palladium-103 prostate seed implants on bone scan.
Topics: Aged; Artifacts; Bone Neoplasms; Brachytherapy; Gamma Rays; Humans; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Scattering, Radiation; Technetium Tc 99m Medronate | 2000 |
Fifteen-year minimum follow-up of a prostate brachytherapy series: comparing the past with the present.
Topics: Brachytherapy; Cohort Studies; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Survival Analysis | 2000 |
Rectal function following prostate brachytherapy.
Topics: Aged; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Quality of Life; Radioisotopes; Rectum; Surveys and Questionnaires | 2000 |
The effect of disease and treatment-related factors on biopsy results after prostate brachytherapy: implications for treatment optimization.
Topics: Biopsy, Needle; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Regression Analysis; Retrospective Studies; Time Factors | 2000 |
A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction.
Topics: Age Factors; Brachytherapy; Erectile Dysfunction; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neurons; Palladium; Phosphodiesterase Inhibitors; Piperazines; Prostate; Prostatic Neoplasms; Purines; Radioisotopes; Radiotherapy Dosage; Regression Analysis; Sildenafil Citrate; Sulfones | 2000 |
Combined 3-dimensional conformal radiotherapy and transperineal Pd-103 permanent implantation for patients with intermediate and unfavorable risk prostate cancer.
Topics: Adult; Aged; Brachytherapy; Chemotherapy, Adjuvant; Disease-Free Survival; Follow-Up Studies; Humans; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Risk; Time Factors | 2000 |
Well-ionization chamber response relative to NIST air-kerma strength standard for prostate brachytherapy seeds.
Topics: Air; Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Quality Assurance, Health Care; Radioisotopes; Radiometry; Radiotherapy Planning, Computer-Assisted | 2000 |
The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma.
Topics: Brachytherapy; Carcinoma; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Survival Rate | 2000 |
Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy.
Topics: Brachytherapy; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Tomography, X-Ray Computed; Urethra | 2000 |
Calibration, calculation, and prescription issues in permanent prostate brachytherapy with (103)Pd.
Topics: Brachytherapy; Calibration; Humans; Male; Palladium; Practice Guidelines as Topic; Prostatic Neoplasms; Radiation Oncology; Radioisotopes; Radiotherapy Dosage; Societies, Medical | 2001 |
Regarding Blasko et al. palladium-103 brachytherapy for prostate carcinoma. IJROBP 2000;46:839-850.
Topics: Brachytherapy; Humans; Male; Palladium; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiotherapy Dosage; Treatment Failure; Ultrasonography; Urethra | 2000 |
125 Gy or 135 Gy? Comments on the American Brachytherapy Society article by Beyer et al. IJROBP 2000;47:273-275.
Topics: Brachytherapy; Calibration; Cancer Care Facilities; Humans; Iodine Radioisotopes; Male; Palladium; Practice Guidelines as Topic; Prostatic Neoplasms; Radiation Oncology; Radioisotopes; Radiotherapy Dosage; Reference Standards; Societies, Medical | 2001 |
American Brachytherapy Society recommendations for clinical implementation of NIST-1999 standards for palladium-103 brachytherapy: in regard to Beyer et al. IJROBP 2000;47:273-275.
Topics: Humans; Male; Palladium; Practice Guidelines as Topic; Prostatic Neoplasms; Radiation Oncology; Radioisotopes; Radiotherapy Dosage; Review Literature as Topic; Societies, Medical | 2001 |
In regard to the American Brachytherapy Society recommendations for 103palladium brachytherapy. Beyer et al. IJROBP 2000;47:273-275.
Topics: Algorithms; Brachytherapy; Cancer Care Facilities; Humans; Male; Palladium; Practice Guidelines as Topic; Prostatic Neoplasms; Radiation Oncology; Radioisotopes; Radiotherapy Dosage; Reference Standards; Societies, Medical | 2001 |
In regard to Beyer, Nath, and Butler et al. IJROBP 2000;47:273-275.
Topics: Brachytherapy; Humans; Male; Palladium; Physical Phenomena; Physics; Practice Guidelines as Topic; Prostatic Neoplasms; Radiation Oncology; Radioisotopes; Radiotherapy Dosage; Societies, Medical | 2001 |
Retrospective stratification of a consecutive cohort of prostate cancer patients treated with a combined regimen of external-beam radiotherapy and brachytherapy.
Topics: Analysis of Variance; Brachytherapy; Cohort Studies; Confidence Intervals; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Retrospective Studies; Risk Factors; Time Factors | 2001 |
Effect of Foley catheters on seed positions and urethral dose in (125)I and (103)Pd prostate implants.
Topics: Brachytherapy; Catheters, Indwelling; Device Removal; Humans; Iodine Radioisotopes; Male; Models, Theoretical; Palladium; Physical Phenomena; Physics; Prostatic Neoplasms; Radiation Dosage; Radioisotopes; Urethra; Urinary Catheterization | 2001 |
The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd.
Topics: Anisotropy; Brachytherapy; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Models, Theoretical; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry | 2001 |
A theoretical derivation of the nomograms for permanent prostate brachytherapy.
Topics: Brachytherapy; Humans; Male; Models, Statistical; Models, Theoretical; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry | 2001 |
Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy.
Topics: Brachytherapy; Foreign-Body Migration; Humans; Lung; Male; Palladium; Prostatic Neoplasms; Radiography, Thoracic; Radioisotopes; Retrospective Studies | 2001 |
A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction.
Topics: Adenocarcinoma; Aged; Brachytherapy; Erectile Dysfunction; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Penis; Phosphodiesterase Inhibitors; Piperazines; Prostatic Neoplasms; Purines; Radiation Dosage; Radioisotopes; Retrospective Studies; Sildenafil Citrate; Sulfones | 2001 |
Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method.
Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Analysis of Variance; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Logistic Models; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Urination Disorders | 2001 |
Temporary PSA rises and repeat prostate biopsies after brachytherapy.
Topics: Adenocarcinoma; Biomarkers, Tumor; Biopsy; Brachytherapy; Diagnosis, Differential; False Positive Reactions; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Proteins; Neoplasm, Residual; Palladium; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radioisotopes; Salvage Therapy; Time Factors; Unnecessary Procedures | 2001 |
Five-year biochemical outcome after prostate brachytherapy for hormone-naive men < or = 62 years of age.
Topics: Adenocarcinoma; Adult; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Life Tables; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioisotopes; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome | 2001 |
Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Brachytherapy; Disease-Free Survival; Gonadotropin-Releasing Hormone; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2001 |
The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes | 2001 |
Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
Topics: Aged; Brachytherapy; Carcinoma; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Perineum; Prostate; Prostatic Neoplasms; Radioisotopes; Radiometry; Retrospective Studies; Ultrasonography | 2001 |
Argon plasma coagulation for rectal bleeding after prostate brachytherapy.
Topics: Argon; Brachytherapy; Gastrointestinal Hemorrhage; Humans; Iodine Radioisotopes; Laser Coagulation; Male; Palladium; Proctitis; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Rectal Diseases | 2001 |
A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of 125I and 103Pd.
Topics: Adenocarcinoma; Brachytherapy; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Neoplasms; Neoplasms, Squamous Cell; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy | 2001 |
Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
Topics: Aged; Aged, 80 and over; Algorithms; Biopsy; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Palladium; Proportional Hazards Models; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Survival Rate; Ultrasonography, Interventional | 2002 |
Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation.
Topics: Adult; Aged; Analysis of Variance; Androgen Antagonists; Brachytherapy; Combined Modality Therapy; Follow-Up Studies; Goserelin; Humans; Iodine Radioisotopes; Leuprolide; Male; Middle Aged; Neoplasm Staging; Palladium; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Retrospective Studies; Risk; Treatment Failure | 2002 |
The dosimetry of prostate brachytherapy-induced urethral strictures.
Topics: Aged; Aged, 80 and over; Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Ultrasonography, Interventional; Urethra; Urethral Stricture | 2002 |
Erectile function after permanent prostate brachytherapy.
Topics: Adenocarcinoma; Aged; Analysis of Variance; Brachytherapy; Coitus; Erectile Dysfunction; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Penile Erection; Prostatic Neoplasms; Radioisotopes; Surveys and Questionnaires | 2002 |
The role of endorectal coil MRI in patient selection and treatment planning for prostate seed implants.
Topics: Brachytherapy; Combined Modality Therapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Staging; Palladium; Patient Selection; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Regression Analysis | 2002 |
Dosimetric analysis of urinary morbidity following prostate brachytherapy (125I vs. 103Pd) combined with external beam radiation therapy.
Topics: Brachytherapy; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy Planning, Computer-Assisted; Time Factors; Urinary Tract | 2001 |
Edema-induced increase in tumour cell survival for 125I and 103Pd prostate permanent seed implants--a bio-mathematical model.
Topics: Brachytherapy; Cell Survival; Edema; Humans; Iodine Radioisotopes; Male; Models, Theoretical; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry; Radiotherapy; Time Factors | 2002 |
Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy.
Topics: Adult; Aged; Brachytherapy; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Rectal Diseases; Regression Analysis | 2002 |
Prognostic significance of race on biochemical control in patients with localized prostate cancer treated with permanent brachytherapy: multivariate and matched-pair analyses.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Black People; Brachytherapy; Disease-Free Survival; Humans; Iodine Radioisotopes; Male; Matched-Pair Analysis; Middle Aged; Multivariate Analysis; Neoplasm Staging; Palladium; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Treatment Outcome; White People | 2002 |
Biologically effective dose for permanent prostate brachytherapy taking into account postimplant edema.
Topics: Algorithms; Brachytherapy; Edema; Gold Radioisotopes; Half-Life; Humans; Iodine Radioisotopes; Linear Models; Male; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radioactivity; Radioisotopes; Relative Biological Effectiveness; Time Factors | 2002 |
Effect of prostatic edema on CT-based postimplant dosimetry.
Topics: Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Palladium; Physical Phenomena; Physics; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rectum; Tomography, X-Ray Computed; Urinary Bladder | 2002 |
Dosimetric parameters for three low-energy brachytherapy sources using the Monte Carlo N-particle code.
Topics: Anisotropy; Biophysical Phenomena; Biophysics; Brachytherapy; Humans; Iodine Radioisotopes; Male; Monte Carlo Method; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2002 |
Experimental determination of the anisotropy function for the model 200 103Pd "light seed" and derivation of the anisotropy constant based upon the linear quadratic model.
Topics: Anisotropy; Brachytherapy; Humans; Male; Models, Statistical; Models, Theoretical; Monte Carlo Method; Palladium; Phantoms, Imaging; Prostatic Neoplasms; Software | 2002 |
Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy.
Topics: Adenocarcinoma; Aged; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Treatment Outcome | 2002 |
Permanent prostate brachytherapy-induced morbidity in patients with grade II and III obesity.
Topics: Adenocarcinoma; Aged; Brachytherapy; Erectile Dysfunction; Health Status; Humans; Iodine Radioisotopes; Male; Middle Aged; Obesity; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Radioisotopes; Radiometry; Treatment Outcome; Urologic Diseases | 2002 |
Interstitial thermal therapy in patients with localized prostate cancer: histologic analysis.
Topics: Aged; Humans; Hyperthermia, Induced; Male; Middle Aged; Necrosis; Palladium; Prostate; Prostatic Neoplasms | 2002 |
Some treatment planning considerations for 103Pd and 125I permanent interstitial implants.
Topics: Brachytherapy; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiometry | 1992 |
Transrectal ultrasound-guided interstitial radiation therapy for localized prostate cancer.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Brachytherapy; Evaluation Studies as Topic; Humans; Male; Needles; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Ultrasonography | 1991 |
Transrectal ultrasound-guided interstitial radiation therapy for localized prostate cancer.
Topics: Brachytherapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Ultrasonography | 1991 |